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ABSTRACT 
EFFECTS OF HZE IRRADIATION ON CHEMICAL NEUROTRANSMISSION 
IN RODENT HIPPOCAMPUS 
Mayumi Machida 
Eastern Virginia Medical School, 2009 
Director: Dr. Gyorgy Lonart 
Space radiation represents a significant risk to the CNS (central nervous system) 
during space missions. Most harmful are the HZE (high mass, highly charged (Z), high 
energy) particles, e.g. 56Fe, which possess high ionizing ability, dense energy deposition 
pattern, and high penetrance. 
Accumulating evidence suggests that radiation has significant impact on cognitive 
functions. In ground-base experiments, HZE radiation induces pronounced deficits in 
hippocampus dependent learning and memory in rodents. However, the mechanisms 
underlying these impairments are mostly unknown. 
Exposure to HZE radiation elevates the level of oxidation, resulting in cell loss, 
tissue damage and functional deficits through direct ionization and generation of reactive 
oxygen species (ROS). When hippocampal slices were exposed to ROS, neuronal 
excitability was reduced. My preliminary results showed enhanced radio-vulnerability of 
the hippocampus and reduction in basal and depolarization-evoked [ H]-norepinephrine 
release after HZE exposure. These results raised the possibility that HZE radiation 
deteriorates cognitive function through radiation-induced impairments in hippocampal 
chemical neurotransmission, the hypothesis of this dissertation. 
In Aim 1 I have focused on the effects of HZE radiation on release of major 
neurotransmitter systems in the hippocampus. I have further extended my research on the 
levels of receptors of these systems in Aim 2. In Aim 3, I have studied the level of 
oxidation in membranes of my samples. 
My research reveals that HZE radiation significantly reduces hyperosmotic 
sucrose evoked [3H]-glutamate and [14C]-GABA release both three and six months post 
irradiation. The same radiation regimen also significantly enhances oxidative stress as 
indicated by increased levels of lipid peroxidation in the hippocampus, suggesting that 
increased levels of lipid peroxidation may play a role in reduction of neurotransmitter 
release. HZE radiation also significantly reduces levels of neurotransmitter receptors 
critical to synaptic plasticity; glutamatergic NMDA (TV-methyl /^-aspartate) receptors and 
pi adrenergic receptors, three months post irradiation. By six months post irradiation, the 
levels of these receptors are returned to normal, implying that partial repair may take 
place. 
My findings demonstrate that a single dose of HZE radiation alters the 
neurochemical environment in the hippocampus, which may underlie radiation-induced 
cognitive dysfunction. 
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INTRODUCTION TO THE PRESENT STUDY 
In the 20-year Strategic Program Plan (SPP) for Space Radiation Health Research 
(SRHR), NASA has identified four major health concerns regarding exposure to space 
HZE (high mass, highly charged (Z), high energy) radiation; 1) acute radiation 
syndromes, 2) degenerative tissue effects, 3) carcinogenesis, and 4) damage to the 
Central Nervous System (CNS) (1). Currently, with the possible exception of cataracts, 
there are no direct human data available for space radiation risk assessment (2). The CNS 
risks are classified as acute and delayed radiation effects (1), and the late delayed effects 
of radiation are the major concern in estimating risks to crew members (3, 4). Currently, 
the following delayed risks are reported; 1) deterioration in motor function (5), 2) 
behavioral impairments mediated by the dopaminergic system (6-8) and 3) cognitive 
dysfunction (9, 10), with no proven mitigation strategies (2). These risks may be 
enhanced by synergistic effects such as bone loss, cardiovascular alterations, and 
impaired sensory-motor adaptation (1, 11). NASA plans to return humans to the Moon 
by 2019 and to Mars by 2030. They have placed high priority on investigating CNS risks 
(1), as CNS injury may cause severe interference with job performance during an 
extended space mission to Mars. Phase 1 of this plan (2006 -2013) emphasizes the 
The model journal for this dissertation is Radiation Research. 
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urgent needs to; 1) develop a new risk model to reduce uncertainties regarding radiation 
induced CNS damage. 2) develop experimental evidence for radiation induced CNS 
damage, and 3) validate permissible exposure limits for space radiation in terms of CNS 
functions (12). 
Studies with conventional radiation, e.g., X-rays and y-rays, in ground based 
settings have established deleterious effects of ionizing radiation on the human brain. 
Long-term studies with childhood cancer survivors revealed that cranial radiation therapy 
often results in progressive cognitive dysfunction (13-16). Young and adult patients of 
acute lymphoblastic leukemia and brain tumors who had received cranial radiation 
therapy display a delayed and progressive decline in cognitive performance including 
impairments in attention, visual perceptual skills, executive function, and memory (75). 
Ris and co-workers reported that brain tumor survivors had a 17.4 point decrease in full 
scale intelligence quotient (IQ) four years after radiation therapy even when moderate 
doses of radiation were applied (14). The neuronal mechanisms that underlie these effects 
remain mostly unknown. Possible causes include demyelination suggested by quantitative 
magnetic resonance imaging (MRI) studies that detected white matter necrosis (15). 
Since the damage correlated with decreased attention, lower IQ and academic 
achievement (16), this histopathological change has been hypothesized as a mechanistic 
base for radiation induced cognitive dysfunction (13). Rodents given a 25 Gy dose of X-
ray radiation have been used extensively to investigate the histopathology of the 
radiation-induced damage, as this dose induces vascular lesions as well as radionecrosis 
that is associated with demyelination one year after irradiation (17). 
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Research on hippocampal neurogenesis has revealed that radiation may induce 
cognitive impairments even at doses that are well below the threshold for producing 
histopathological changes. Whole brain irradiation of mice subjected to a single mild 
dose (10 Gy) of X-rays showed reduced performance in a Barnes maze, a hippocampal-
dependent spatial learning test (18). Since the same dose of radiation nearly abolishes the 
production of new neurons in rodents one or two months post irradiation (19, 20), it has 
been suggested that radiation-induced cognitive dysfunction may depend on adult 
neurogenesis in the hippocampus. However, there was no correlation between radiation 
induced suppression of adult neurogenesis and spatial learning tested in a different 
behavioral paradigm, e.g. Morris water maze (21, 22). In addition, when other techniques 
were used to suppress adult neurogenesis, they failed to establish an unambiguous link 
between adult neurogenesis and learning and memory (23, 24). Thus, a causative 
relationship between radiation induced suppression of neurogenesis and radiation induced 
cognitive impairment still awaits clarification (24). 
An alternative neuronal mechanism of radiation-induced cognitive dysfunction is 
perturbation of chemical neurotransmission, a mechanism mostly independent of 
neurogenesis (25). Transduction of neuronal signal may be achieved by electrical 
coupling of pre- and postsynaptic elements at electrical synapses. However, the 
overwhelming majority is chemical synapses, which use chemical substances for 
transmission". Exposure to radiation results in the generation of toxic free radicals (26, 
27) which affects neurotransmission (28-31). When a hippocampal slice preparation was 
exposed to H2O2, an experimental model to assess effects of HZE radiation (28), the 
In the rest of the text, the term "neurotransmission" will refer to "chemical neurotransmission". 
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exposure altered neuronal excitability, the ability to generate action potentials (29), and 
reduced synaptic efficacy at both inhibitory and excitatory synapses (30). H2O2 also 
suppressed [K+]-depolarization-evoked [3H]-glutamate release from isolated cortical 
nerve terminals, suggesting that radiation induced reactive oxygen species (ROS) 
production may perturb the functional integrity of release machinery (31). 
Currently neurochemical research on space HZE radiation effects has been mostly 
limited to nigrostriatal dopaminergic (DA) and cholinergic neurotransmission (5, 32, 33), 
a brain region mostly involved in movement coordination (34). Joseph et al found that 0.1 
to 1.0 Gy of HZE radiation significantly reduced the enhancement of depolarization-
evoked DA release by oxotremorine, muscarinic cholinergic receptor agonist (5). This 
effect was region-specific, as decrements were observed only in the striatum but not in 
the hippocampus (35). 
Much less understood are the effects of space radiation on hippocampal 
neurotransmission, despite the well documented HZE radiation-induced impairments in 
hippocampus dependent behavior (9, 10, 36), and radio-sensitivity of the region (28, 37). 
In line with these previous reports, my preliminary results also demonstrated significantly 
enhanced radio-vulnerability of the hippocampus (Chapter I, Preliminary Results for a 
full detail). Thus, in this study, I have focused on the effects of HZE radiation on 
chemical neurotransmission in the hippocampus. My hypothesis is that HZE radiation 
disrupts functional integrity of hippocampal neurotransmission, which may be a 
component of radiation-induced cognitive dysfunction. 
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Since major events in synaptic neurotransmission are release of neurotransmitters 
and activation of neurotransmitter receptors, I addressed possible HZE effects on these in 
the following specific aims. 
In Aim 1, I tested effects of HZE radiation on release of major hippocampal 
neurotransmitters. I assayed basal and hyperosmotic-shock evoked release from 
glutamatergic, GABAergic (y-amino-butyric acid), and noradrenergic systems 
(Chapter II). Hyperosmotic sucrose evoked release has been used as a measure of the size 
of the readily releasable pool, which reflects release probability (38) and synaptic 
strength (39). Glutamate is the major excitatory transmitter in the CNS and the 
participation of glutamatergic NMD A receptors in long-term potentiation (LTP) and 
depression (LTD) provides a strong link between the glutamatergic systems and the 
mechanisms of learning and memory (40). GABA is the major inhibitory transmitter in 
the CNS, and behavioral/pharmacological studies have suggested that GABA receptor 
blockade can improve hippocampal dependent learning and memory (41). NE is also 
implicated in synaptic plasticity; a- and P-adrenergic receptor manipulations modulate 
LTP in hippocampal pathways (42, 43) and learning tasks (44). My working hypothesis 
was that HZE radiation perturbs release of these hippocampal neurotransmitters, which 
play critical roles in hippocampal dependent learning and memory. 
In Aim 2, I tested the effects of HZE radiation on levels of neurotransmitter 
receptors (Table 1) by quantitative western blot analysis to elucidate biochemical 
correlates of possible changes in neurotransmission (Chapter III). My working hypothesis 
was that HZE radiation may affect these protein levels, and in turn these may lead to 
alterations in synaptic strength, giving rise to impaired learning and memory. 
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TABLE 1A 

























Synaptic Proteins Evaluated in Quantitative Western Blot Analysis 
Description Proteins Mw 
Synaptic vesicular protein Synaptophysin 
Vesicular glutamate transporter VGlutl 
Scaffold protein for glutamatergic re PSD-95 




280kDa (2a, 2b), 70kDa (2c) 
Loading control Actin 42 kDa 
Loading control VCP 97 kDa 
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Aim 3 was designed to test HZE effects on lipid peroxidation in the 
hippocampus (Chapter IV). By definition, ionizing radiation generates ions, which 
increase the formation of free radicals and reactive oxygen species (ROS). Imbalance 
between the pro-oxidants and anti-oxidants may cause oxidative stress, e.g. oxidation of 
membranes. My working hypothesis was that lipid peroxidation of membranes may 
underlie impairments in hippocampal neurotransmission. 
To investigate these specific aims, I exposed rats to single doses of 0.6, 1.4, 2.0 
Gy of HZE (56Fe, 1 GeV/n, 150 keV/|j.m) radiation, or sham radiation. The dose of 2.0 
Gy was chosen based on my preliminary study where 2.0 Gy significantly inhibited basal 
and evoked [3H]-norepinephrine release from rat hippocampal slices (Chapter I, 
Preliminary Results). One point four Gy was chosen to approximate doses that inhibit 
hippocampus dependent cognitive performance previously reported (9, 10, 36). I have 
chosen 0.6 Gy as the lowest test dose, since our behavior data displayed highly variable 
performance of 0.6 Gy irradiated animals in hippocampus dependent spatial learning test, 
which implies that the dose is capable to induce neurochemical change in hippocampus, 
but a degree of change depends on sensitivity to radiation within each individual (45). 
As discussed earlier, it is the delayed effects that may lead to severe neurological 
consequences in the CNS (46, 47). In this study, animals were sacrificed three and six 
months post-irradiation to investigate the early and late delayed radiation effects. 
I used synaptosomal preparation to evaluate effects of HZE irradiation on 
hippocampal neurotransmission and protein levels. Synaptosomes are isolated nerve 
terminals, and have been used as an experimental model system to study the structure and 
function of the synapse (48), and synaptic plasticity (49). 
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My findings indicate that a single treatment with 0.6 Gy of 56Fe HZE particlesb 
(1 GeV/n, whole-brain irradiation) significantly disturbs functional integrity of the 
release machinery of rat hippocampal synaptosomes, and results in the reduction of 
evoked [3H]-glutamate and [14C]-GABA release three months post irradiation. A 
pronounced change has also been found at the 6 month time-point, indicating that the 
effects are persistent. Exposure to 56Fe HZE radiation also significantly perturbs levels of 
glutamatergic NMDA receptors and P adrenergic receptors, while levels of marker 
proteins for glutamatergic nerve terminals, and glutamatergic synaptic vesicles are not 
significantly altered, thus it is unlikely that observed reduction in glutamatergic release is 
caused by radiation-induced depletion of glutamatergic store or apoptotic damage of 
nerve terminals. Increased level of lipid peroxidation after exposure may be a possible 
mechanism of disrupted neurotransmission in the hippocampus. 
Considering critical roles of glutamatergic and GABAergic systems, and NMDA 
receptors and p adrenergic receptors in learning and memory, my findings provide 
experimental evidence which underlie radiation-induced cognitive dysfunction. 
INTRODUCTION TO SPACE RADIATION BIOLOGY 
Radiation is a process in which energy radiates, i.e. energy travels outward in 
straight lines to all directions from a source. When radiated energy hits atoms or 
molecules, it may lead to excitation or ionization of them. Excitation is where energy 
causes an electron in an atom or molecule move to a higher energy level without actual 
'Fe particles are discussed in Chapter I, Introduction to Space Radiation Biology. 
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ejection of the electron, while ionization is a process where the incident energy is 
sufficient to eject orbital electrons from the atom or molecule. Ejected electrons are 
capable of causing damage to biological materials by breaking a chemical bond and 
initiating a chain of events, or to induce free radical production. An important 
characteristic of potentially hazardous radiation is the ability to ionize, and such radiation 
is classified as ionizing radiation. 
Ionizing radiation is categorized as either electromagnetic or particulate, 
depending on the source of energy. X-rays are a conventional example of electromagnetic 
radiation and are used in clinical practice. The source of particulate radiation could be 
electrons, protons, a-particles, neutrons and heavy charged ions (HZE, high mass, 
highly charged (Z), high energy). 
The biological effects of radiation are caused by either direct or indirect action 
of ionization. Direct action of radiation is where energy directly interacts with targets in 
cells and initiates a chain of events that leads to a biological change (Fig. 1, direct action). 
Alternatively, radiation may interact with other atoms or molecules in the cell, for 
example, water, to produce reactive oxygen species (ROS) that are able to diffuse to 
critical targets and inflict damage (Fig. 1, indirect action). A principal target for direct 
action is chromosomal DNA, as depicted in Figure 1. 
Galactic cosmic radiation (GCR) is a major constituent of space radiation, which 
is composed of protons (85%), helium (14%) and heavier HZE particles (1%) (2). 
Although protons make up a large portion of the radiation spectrum, no significant effect 
of proton radiation at any dose on behavibral and neurochemical endpoints has been 




FIG. 1. Direct and indirect actions of ionizing radiation. In direct action, an emitted 
electron (e") interacts with a target, for example, DNA helix, to produce an insult. In 
indirect action, an electron interacts with, for example, a water molecule to produce ROS, 
here a hydroxyl radical (OH"), which in turn produces the damage to the DNA. (Modified 
from Hall, 2006; ref. 46) 
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Thus, the general consensus is that HZE particles represent the most hazardous type of 
radiation in space. Human exposure to HZE in space was first described as an episode 
during the lunar missions of the 1970's, when astronauts "saw" light flashes with eyes 
closed in complete darkness. This phenomenon was caused by HZE particles crossing the 
retina. It has been estimated (53) that on a 3-year mission to Mars, 3% of cells in the 
body would be traversed by HZE (56Fe) particles even behind aluminum shielding of 4 
g/cm300. 
HZE particles are nuclei of elements; e.g. carbon, neon, argon, or iron. They are 
positively charged because some or all of the planetary electrons have been stripped away 
(46). In ground based studies, HZE particles must be accelerated to energies of mega 
(106) to giga (109) electron volts, therefore, can be produced in only specialized facilities. 
HZE radiation has a characteristic pattern of energy deposition in a defined range along a 
linear track. Figure 2 shows computer simulations for track structures of proton (A) and 
three types of HZE particles (B, C, D) in liquid water to estimate energy distribution in 
biological matter (54). In contrast with a diffuse pattern of proton (A), HZE particle 
tracks take the appearance of a dense "bottle brush" pattern with a central "core". In the 
core, the local dose may be quite high, but may drop to zero just a few microns away. 
Thus, HZE particles are categorized as high LET (linear energy transfer) radiation per 
unit length of track. 
Another important property of HZE particles is that they undergo nuclear 
fragmentation reactions to produce multiple secondary particles (55). These secondary 
particles, whose effects are similar to X-rays, create their own tracks (delta-ray) and may 
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FIG. 2. Computer simulation of tracks of representative particulate radiation: proton 
(A), carbon (B), silicon (C), and iron (D) ion passing through a thin slab (1 um) of liquid 
water with initial energy 100 MeV/nucleon. The particles are started in positive Z-
direction, and the coordinates are given in Angstrom (A), Lateral tracks indicate delta-ray 
from secondary particles. (From Dingfelder, 2006; ref 54) 
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delta-ray tracks are shown along the longitudinal primary trajectories. 
Also, as the panels B, C, and D show, the greater the nuclear charge (Z), the 
higher the ionization density becomes, which leads to the increased probability of a direct 
interaction between the particle track and target molecule. A characteristic dense 
pronounced track of 56Fe shows that heavy HZE particles could be more devastating. 
Another important feature of HZE particles is so called "bystander effect", which 
is illustrated in Figure 3 (55). Bystander effect is when an isolated individual cell in a 
population is traversed by a particle, both the "hit" cell and many of its "un-hit" 
neighbors (bystanders) respond to radiation exposure (56-58). The effect is likely 
mediated by damage-inducing factor(s), as transfer of culture medium from an exposed 
culture to unexposed cells often exhibits the effect. Protection by ROS (reactive oxygen 
species) scavengers such as superoxide dismutase (SOD) or catalase blocks the bystander 
effect in some systems, while proteases block the effect in others, thus it is assumed that 
damage in a "hit" cell may lead to the spread of either radical products or signaling 
proteins to neighboring cells. This effect may persist for several years (58). Although 
currently bystander effects have been reported in preparations exposed at low dose, the 
existence of the effect provides evidence for damage amplification. 
Considering the highly-layered and interconnected structure of the CNS, the 
possibility of HZE tracks to cause a "functional micro-lesion" via its characteristic dense 
energy deposition pattern or via bystander effect in the organ is extremely high (55), in 
contrast to isotropic tissues such as liver Or connective tissue. Thus, the CNS has been 
suggested as a system of the body that might be particularly sensitive to HZE particles. 
14 
Radiation 
Transfer of Signals 
by Intercellular junctions 
* * 
FIG. 3. "Bystander effect". Damage created in a cell struck by a single charged 
particle radiation leads to the spread of signals or toxic products to many neighboring 
cells via intercellular junctions, soluble molecules, or remodeling of the extracellular 
matrix. The "bystander effect" amplifies the damage from charged particles. •*: DNA 
damage. (From Nelson, 2003; ref. 55) 
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It is estimated that during a three-year mission to Mars, 2% to 13% of cells in the CNS 
would be directly hit at least once by HZE particles (53). 
HZE radiation is a heterogeneously composed beam including elements heavier 
than helium 4He. On ground level experiments, however, effects of individual ions, such 
as 56Fe, are investigated extensively to simulate effects of HZE radiation. 56Fe (Z — 26) is 
the most abundant element in the HZE flux, followed by 28Si (Z = 14) (52). 56Fe has the 
highest nuclear binding energy derived from the strong nuclear force (Fig. 4). Nuclear 
binding energy is defined as energy required for disassembling a nucleus into free 
unbound neutrons and protons per nucleon. High binding energy of 56Fe (8.79 
MeV/nucleon) explains an increase in stability toward formation of 56Fe, indicated by the 
arrows in Figure 4 (59). Much lighter elements tend to fuse together to yield heavier 
elements such as 56Fe, and much heavier elements split apart to yield lighter elements, 
also leading to 56Fe production. 
Accumulating evidence indicates that 56Fe particles can induce distinctive effect 
on biological materials. When behavioral toxicity caused by direct action of HZE on 
gastrointestinal system was evaluated using conditioned taste aversion learning, effects of 
56Fe was significantly greater than that of 4He, 20Ne, 40Ar, and even the heavier 93Nb (Fig. 
5) (6, 60). One characteristic of 56Fe effects is its extremely steep dose-response curve 
(P, di), as observed in Figure 5. 56Fe also can induce significant effects on motor 
performance assessed in wire suspension test (5), and prevent the acquisition of an 
amphetamine-induced conditioned taste aversion (8). Since these behaviors depend on 
the integrity of the central dopaminergic transmission, it has been suggested that the locus 
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FIG. 4. Binding energy / nucleon for the most stable isotope of each naturally 
occurring element. 6Fe possesses the highest binding energy per nucleon (8.79 MeV/n). 
As a result, stability is exerted in the direction toward 56Fe, as indicated by the arrows. 
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FIG. 5. Dose effects of selected HZE particles on conditioned taste aversion (GTA) 
production. Rats were presented a novel 10% sucrose solution and immediately exposed 
to one of the following HZE particles: 56Fe, iron; 93Nb, niobium; 20Ne, neon; 40Ar, argon; 
4He, helium. The acquisition of a CTA was assessed by subsequent intake of the normally 
preferred sucrose solution, and expressed as the percentage of conditioning day sucrose 
intake: Higher dose produced a corresponding decrease in all types of particles. Among 
these particles, 56Fe particles showed significantly greater behavioral toxicity than other 
particles. (From Rabin, 1994; ref. 6) 
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Joseph et al. suggested the 56Fe exposure induced deficits in dopaminergic 
neurotransmission are due to decreased sensitivity to muscarinic receptors, which 
indirectly contributes to dopamine dependent behaviors. A proposed mechanism 
underlining the deficits is radiation induced changes in striatal membrane structure and 
fluidity caused by lipid peroxidation, which is known to affect a variety of 
neurotransmitter receptor systems (62). Deleterious effects of 56Fe radiation on behavior 
were also found in hippocampal dependent learning and memory tests (9, 10, 36). The 
hippocampus plays a major role in acquisition of spatial information, temporary storage 
of that information, and transfer of information to long term storage to cortical areas (63). 
Failure of the hippocampus results in anterograde memory loss that interferes with proper 
cognitive functions. The region has been known to be highly vulnerable to insults such as 
trauma, ischemia, stress, aging (64), and also radiation. Even extremely low doses (0.005 
Gy) of 4 Ar or 56Fe induce a decrease in synaptic density and synaptic spine length in the 
mouse hippocampus (65, 66). 
In animal behavioral studies, hippocampal integrity is often assayed in spatial 
memory tasks. 1.0 Gy to 1.5 Gy of 56Fe radiation caused impairment in spatial memory 
performance of rodents tested in Morris water maze (9, 27), Barns maze (67), and 8-arm 
radial maze (7 0). These results suggest a detrimental effect of 56Fe particles on 
hippocampus dependent cognitive functions, although the underling neurochemical 
mechanisms are not fully understood. 
Considering these significantly pronounced effects, in this study I choose Fe 
particles to simulate effects of space radiation. 56Fe particles were accelerated to energies 
of 1 GeV/n (giga electron volts per nucleon) in the Alternating Gradient Synchrotron in 
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Brookhaven National Laboratory of NASA Space Radiation Laboratory (Chapter II, 
Materials and Methods in detail), and utilized to irradiate rats. 
PRELIMINARY RESULTS 
Initially, I had tested effectiveness of 56Fe particles on catecholaminergic 
neurotransmission in several brain regions three month post irradiation. I had used a 
slice preparation, which maintains integrity of local neuronal circuits and glial 
connection, thus, is suitable to assess neurotransmission ex vivo. I tested transmission of 
norepinephrine (NE) and dopamine (DA), which plays important roles in learning and 
memory (63), and are vulnerable to radiation (68, 69). 
Unlike glutamatergic and GABAergic regulation which rely on dual glial-
neuronal reuptake property (discussed in Chapter II), catecholamine transmitters are 
mostly cleared by transporters on presynaptic terminals. Thus the action of NE or DA is 
terminated largely by removal of these by transporters from the synaptic cleft and either 
recycled to synaptic vesicles or enzymatically degraded (70). In my experiments, 
pargyline, an inhibitor of monoamine oxidase, the major degradative enzyme, was added 
to a buffer to prevent conversion of [3H]-DA or -NE to [3H]-metabolites. Thus, 
measurement of 3-H indexes [3HJ-catecholamine release, not [3H]-metabolites. 
Three brain regions were tested site-by-site: hippocampus, associative cortex 
and striatum. Since NE and DA are not uniformly distributed, noradrenergic nerve 
terminals in hippocampal slices were labeled with [ H]-NE, while dopaminergic 
terminals in striatum and associative cortex were labeled with [3H]-DA. Basal release 
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was determined before a depolarization stimulus, 50 mM KC1, was applied to induce 
evoked release. 
My results demonstrated that exposure to > 2.0 Gy of 56Fe HZE radiation (1 
GeV/n, 150 keV/um) perturbed neurotransmission (Fig. 6), and resulted in significant 
reduction in both basal and [K+]-depolarization-evoked [3H]-NE release from 
hippocampal slices, while [ H]-DA release from cortical and striatal slices was not 
significantly altered under the test condition. 
Using the same experimental approaches, I have measured release after X-ray 
exposure to assess relative biological effectiveness (RBE) of 56Fe radiation. 13 Gy of X-
rays produced similar neurochemical changes as observed with > 2.0 Gy of 56Fe radiation. 
It reduced both basal and [K+]-depolarization-evoked [3H]-NE release from hippocampal 
slices (Fig. 7), while 10 Gy of X-rays did not significantly alter neurotransmitter release 
(data not shown). [3H]-DA release from cortical and striatal slices was not significantly 
altered under any test conditions (Fig. 7). 
In summary, my preliminary results show 1) enhanced radio-sensitivity of the 
hippocampus, and 2) high effectiveness of HZE (56Fe) radiation with RBE value 6.5 in 
inhibiting hippocampal noradrenergic transmission. The results also serve to estimate 
effective 56Fe radiation doses for our main studies. Determination of RBE to a standard 
radiation, or X-rays, is a common practice in radiation research (55, 71). RBE is 
calculated as the ratio of the dose of X-rays to the dose of a test radiation that produces 
the same biological effect. 
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FIG. 6. Over 2 Gy of HZE (56Fe, 1 GeV/n, 150 keV/^m) radiation effects on [3H]-
catecholaminergic release from rat brain slices: associative cortex (A, B); hippocampus 
(C, D); and striatum (E, F). Endogenous norepinephrine (NE) stores in hippocampal 
slices were labeled with [3H]-NE. Endogenous dopamine (DA) stores in striatum and 
associative cortex slices were labeled with [3H]-DA. Catecholamine release was induced 
by depolarization using a 1.5 min pulse of 50 mM KC1 (arrow). Basal and depolarization-
evoked release in response to either 2 or 2.25 Gy of 6Fe radiation was determined in 
comparison with sham treated animals three month post irradiation. Panel A, C, E: 
Representative experiment. Panel B, D, F: Summary data. The fractional release values 
under normal conditions were set to 100% and treatment effects were normalized to 
control. Data are presented as mean ± SEM (n = 4 rats/treatment). *: P < 0.05, Student's 
Mest. 
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FIG. 7. Thirteen Gy of X-ray effects on [3H]-catecholaminergic release from rat brain 
slices: associative cortex (A, B); hippocampus (C, D); and striatum (E, F). Endogenous 
norepinephrine (NE) stores in hippocampal slices were labeled with [3H]-NE. 
Endogenous dopamine (DA) in striatum and associative cortex slices was labeled with 
[3H]-DA. Catecholamine release was induced by depolarization using a 1.5 min pulse of 
50 mM KC1 (arrow). Basal and depolarization-evoked release in response to 13 Gy of X-
rays was determined in comparison with sham treated animals at three month post 
irradiation. Panel A, C, E: Representative experiment. Panel B, D, F: Summary data. The 
fractional release values under normal conditions were set to 100%, and treatment effects 
were normalized to control. Data are presented as mean ± SEM (n = 3 rats/treatment). *: 
P < 0.05, Student's /-test. 
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CHAPTER II 
EFFECTS OF HZE RADIATION ON NEUROTRANSMITTER RELEASE 
BACKGROUND 
In the hippocampus the majority of synaptic activity is driven by the excitatory 
neurotransmitter glutamate and I have focused my attention mostly on the glutamatergic 
system. Direct involvements of glutamate in learning and memory have been established, 
e.g. a critical role of glutamatergic NMD A receptors in long-term potentiation (LTP) 
(72), long-term depression (LTD) (73) and memory (74) has been shown. Disturbance 
of the hippocampal glutamatergic neurotransmission also has been implicated in the 
pathogenesis of neurological disorders, such as schizophrenia (75), and functional decline 
was found during aging (64 for review, 76) 
The processes related to the glutamatergic neurotransmission are schematically 
depicted in Figure 8. The synthesis of glutamate (GLU) occurs from glutamine (GLN) 
through the action of glutaminase (Gln-ase) which is localized in the mitochondria of 
glutamatergic nerve terminals (76) (step 1). Glutamate is then incorporated to synaptic 
vesicles by vesicular glutamate transporter (VGlut, discussed in Chapter III) (77) (step 
2). Glutamate is released from synaptic vesicles into the synaptic cleft upon action 
potential triggered by Ca influx (step 3) and activates lonotropic receptors (AMPA, 
NMD A, kainate (KA) (step 4) to produce excitatory postsynaptic potential (EPSP). 
Glutamate also activates metabotropic receptors (mGluR), which transduce signals to 
enzymatic activity and/or channel activity. The main mechanism for clearing 
extracellular glutamate is by uptake through high-affinity neuronal glutamate transporters 
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FIG. 8. Schematic representation of glutamatergic neurotransmission; 1) synthesis of 
glutamate (GLU) from glutamine (GLN) through the action of glutaminase (Gln-ase). 2) 
storing of glutamate into synaptic vesicles. 3) Ca2+ dependent exocitotic release of 
glutamate. 4) glutamate activation of its receptors (AMPA, AMPA receptors; KA, kainate 
receptors; NMD A, NMD A receptors; mGluR, metabotropic receptors; R-ex, 
extrasynaptic receptors (ionotropic or metabotropic)). 5) uptake of glutamate through 
high affinity transporters (empty box) located in astrocytes and presynaptic terminals. 6) 
synthesis of glutamine from glutamate though the action of glutamine synthetase (Gln-s). 
(From Segovia, 2001; ref. 64) 
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(excitatory amino acid transporter (EAAT)) located in presynaptic terminal or glial 
glutamate transporter (GLT) located in astrocyte surrounding glutamatergic terminals 
(step 5). As for the catabolism of glutamate, the glial enzyme glutamine synthetase (Gln-
s) converts glutamate to glutamine (76) (step 7), which is taken up by neurons and is 
converted to glutamate. 
Glutamate transporters are driven by Na+/K+ electrochemical gradients. The 
transport of one molecule of glutamate is coupled to the co-transport of three Na+ and one 
H+, and the counter-transport of one K+ (step 5). When these gradients are dissipated and 
ionic disequilibrium occurs, glutamate may also be "released" by reverse operation of the 
glutamate transporters (step 6). The physiological role of this Ca2+-independent release of 
glutamate is questioned, but is associated with excitotoxicity in pathological 
circumstances, e.g. ischemia (64). 
As Figure 8 shows, synaptic glutamate concentration is the result of a balance 
between these neuronal-glial release and uptake processes. This dual-component system 
makes it difficult to differentiate between effects on release and re-uptake when brain 
slices are used for release experiments/To circumvent this problem, in the present study, 
we have utilized isolated nerve terminals, synaptosomes (Fig. 9). Synaptosomes are 
prepared by gentle homogenization in iso-osmotic sucrose solution, followed by a series 
of differential centrifugations. The purity of synaptosomal preparation is estimated to be 
about 70% (78). It contains 1) mitochondria, 2) synaptic vesicles, 3) active zone, a 
specialized region of presynaptic plasma membrane where synaptic vesicles fuse, and 4) 
attached fragments of postsynaptic membranes containing signal transducing proteins 
(Fig. 9) (79). Under proper experimental conditions, synaptosomal preparation is 
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FIG. 9. Electron micrograph of rat brain synaptosome. The terminal (T) with 
mitochondria (M) is in contact with dendritic spine containing postsynaptic density 
(PSD) (small arrow) and a spine apparatus (large arrow). Bar, 300 nm. (From Kiebler, 
1999; ref. 80) 
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metabolically active. It respires, takes up oxygen and glucose, maintains a normal 
membrane potential by extruding Na+ and accumulating K+, and upon depolarization, 
releases transmitter in a Ca2+-dependent manner (78). Since glial elements are mostly 
eliminated from synaptosomes, glial source of release and uptake is minimized. 
In addition to glutamate, I have also investigated GABA and NE release 
properties. GABA is the major inhibitory neurotransmitter in the adult hippocampus, 
associated with synaptic inhibition by causing a hyperpolarization of postsynaptic 
membrane through ionotropic GABAA receptors, which is coupled to CI" ion conductance 
(70). GABAB receptors are metabotropic and behavioral studies have suggested that 
GABAB receptor blockade can improve cognition (41). GABA is synthesized from L-
glutamate by GAD (glutamic acid decarboxylase) which localizes at neurons with the 
GABA containing synaptic vesicles. Similar to glutamatergic neurotransmission, GABA 
also has dual glial/neuronal reuptake process and after release, the action of GABA is 
terminated largely by removal from the synaptic cleft by these transporters. 
NE plays a prominent role in hippocampal cognitive function as a neuromodulator. 
It enhances LTP, widely believed to be an important cellular mechanism of learning and 
memory. Mossy fiber LTP in the hippocampus is modulated by both 0- and a l -
adrenergic receptors (43, 81, 82). NE has also been known to display vulnerability to 
ionizing radiation. After X-ray exposure, NE content in rat brain and heart were reduced 
(68) and y radiation reduced NE release in the hippocampus (69). The precise 
mechanisms underling these findings are unknown. A pharmacological study implicates 
reduced mobilization of intracellular Ca2+ stores (83), however, our own studies 
determined only a minor role for internal Ca stores for neurotransmitter release 
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regulation (84). The involvement of hippocampal glutathione's anabolic/metabolic 
pathways was also suggested (85). 
Synaptic vesicles (SV) cycle between functionally heterogeneous subpopulations 
is depicted in Figure 10. After the uptake of neurotransmitters (NT) (step 1), synaptic 
vesicles form a cluster termed the reserve pool (step 2). Next, vesicles are docked at the 
active zone (step 3), and through an ATP-dependent process, the release machinery is 
"primed" (step 4). During priming, fusion core complex, or SNARE complex (soluble N-
ethylmaleimide-sensitive fusion protein attachment protein receptors), is assembled into 
a trans configuration, which contains synaptobrevin (vesicular SNARE motif), SNAP-25 
and syntaxin (target SNARE motif on the plasma membrane). This complex spans 
synaptic vesicle membrane and plasma membrane, and brings these into close proximity. 
Also, synaptotagmin, a putative Ca2+ sensor, constitutively associate with SNARE 
complex. Though these processes, synaptic vesicles become fusion competent and form 
the readily releasable pool (RRP). After fusion (step 5), synaptic vesicles undergo 
endocytosis and recycle via several routes: fast recycling without an endosomal 
intermediate (step 6), or clathrin-mediated endocytosis (step 7) with recycling via 
endosomes (step 8). The total number of vesicles that participates in exo- and endocytosis 
during prolonged stimulation is referred to as the recycling pool. This pool is composed 
of the RRP and the reserve pool, which serves to replenish the RRP upon its depletion 
(86). Using cultured hippocampal neurons, one study estimated 17 - 20 vesicles in the 
reserve pool and 4 - 8 vesicles in RRP, estimating total of 21 - 25 vesicles in the 
recycling pool (86). 
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FIG. 10. Readily Releasable Pool (RRP) in synaptic vesicle cycle. After synaptic 
vesicles are filled with neurotransmitters (NT) (step 1), they form a vesicle cluster that 
serves as a reserve pool (step 2). Filled vesicles dock at the active zone (step 3), and there 
they undergo an ATP-dependent priming reaction (step 4) which makes them competent 
for Ca2+ triggered fusion-pore opening (step 5). Primed synaptic vesicle cluster is termed 
RRP. (Modified from Sttdhof, 2004; ref 86) 
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RRP informs on synaptic release probability (pr) and synaptic strength (38, 87). 
These parameters are actively regulated under physiological conditions, e. g. learning and 
memory related processes (88), and under neurodegenerative conditions (89, 90). 
I used a pulse of hyperosmotic sucrose to probe the size of the RRP (38, 88). The 
30 sec pulse I applied does not induce membrane damage but mimic action potential 
evoked vesicular neurotransmitter release (38, 88, 91) with the exception that it does not 
require Ca2+ influx. This allowed me to bypass possible treatment effects on Ca2+ 
homeostasis and focus on HZE radiation induced modulation of the RRP and changes in 
the "proximal" release machinery proteins that are directly involved in the synaptic 
vesicle cycle. 
Whereas action potential/depolarization evoked release is the most studied, even 
in the absence of action potentials, synapses exhibit low-probability "spontaneous" 
release. This represents mostly fusion of a single synaptic vesicle of a distinct vesicle 
pool (92). Spontaneous release had been considered as a "leak" of neurotransmitter in a 
random Ca independent fashion, however, recent studies revealed that spontaneous 
release may also be Ca sensitive, although to a different degree (93). The physiological 
role of spontaneous release is not clear, but several roles e.g. spine maintenance, have 
been suggested (94). Basal release in my assay may correlate with spontaneous release. 
In my release assay, neurotransmitter pools in synaptosomal preparations were 
first labeled with 3H or I4C tagged neurotransmitter in a low enough concentration that 
would not offset the natural distribution of the endogenous neurotransmitter. In principle, 
release of the radiolabel accurately reflects the endogenous neurotransmitter release. 
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After I determined basal release, release was evoked by applying a stimulus. Basal and 
stimulus evoked neurotransmitter efflux was determined by counting the isotope amounts. 
MATERIALS AND METHODS 
Animals and Irradiation Procedures 
A total of seventy-eight male0 Wistar rats (Harlan Sprague-Dawley, Inc., 
Indianapolis, IN) were used in this study. 49 animals were exposed either to X-rays or 
56Fe radiation, while 29 rats were exposed to the same procedural steps, except that they 
received no radiation. These were termed as sham control animals. The animals were 3 to 
4 weeks old weighing approximately 180 g when they were received at Eastern Virginia 
Medical School (EVMS) or Brookhaven National Laboratory (BNL, Brookhaven, NY) 
animal facility. They were allowed to acclimate for at least one week before radiation 
exposure. 
At about 5 weeks of age, rats were anesthetized with LP. ketamine (80 
mg/kg)/xylazine (8 mg/kg) and placed in a custom-made irradiation jig that held their 
head in a fixed position by a tooth bar. The jig was placed behind a 6 mm lead shield for 
c
 Gender differences in response to radiation have been reported in patients receiving cranial radiotherapy 
(13, 95). These reports found that girls had increased risk for neurocognitive impairments. However the 
underlying mechanisms of gender differences are not well understood. While gender differences to 
radiation have important basic science and practical implications at this exploratory stage of the project, I 
felt that avoiding the possible influences of menstrual cycle was more prudent. Also, previous HZE 
radiation studies mostly used male rodents, allowing more direct comparisons with my studies. 
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X-rays or a 40 mm tungsten shield for HZE that protected the anterior portion of the rats' 
muzzle and the posterior portion of the body from the pinnae backwards. Body doses of 
the cranial dose were 1-3% for X-rays and < 0.8% for HZE. Rats were given a single 
dose of irradiation using either X-rays or 56Fe particles. For X-ray exposure, the animals 
were given whole brain irradiation of 10 or 13 Gy of 200 kVp X-rays at a dose rate of 3 
Gy/min at EVMS. Tron-56 particle radiation (1 GeV/n, LET = 150 keV/um) was 
generated using the Alternating Gradient Synchrotron (AGS) in Brookhaven National 
Laboratory (BNL) of NASA Space Radiation Laboratory (NSRL). The animals were 
given a single dose (0.6, 1.4 or 2.0 Gy) of whole brain irradiation at a dose rate of 0.5 
Gy/min. After a week of recovery time, the rats were transported to EVMS. 
The animals were housed either singularly or in pairs in standard cages in a group 
housing environment, maintained on a 12-h light/dark cycle with lights on from 7:00 AM 
to 7:00 PM. Ambient temperature was maintained at 24.5 ± 0.5°C. The rats were given ad 
libitum access to autoclaved rat chow and water. Their weight was monitored on a 
weekly basis. No specificity of weight loss was observed in any of dose groups. 
Three or six months after irradiation, animals were sacrificed under anesthesia of 
15% halothane in mineral oil, and brain regions of interest were dissected. These time 
points were selected to investigate late-developing radiation effects on the CNS (46), 
One half of the brain tissue was immediately used for making slice or synaptosomal 
preparations for release assay. The other half was kept as dry tissues at -80°C until use 
for western blotting and lipid peroxidation experiments. 
The present project was conducted in accordance with the National Institutes of 
Health guidelines for the care and use of animals in research, and was approved by the 
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Institutional Animal Care and Use Committee of EVMS and by those of BNL. Animal 
facilities at EVMS are accredited by the Association for Assessment and Accreditation of 
Laboratory Animal Care, International. 
Slice and Synaptosomal Preparation 
After anesthesia with 15% halothane in mineral oil and decapitation, brains were 
rapidly removed and placed into ice-cold phosphate buffered saline (PBS), pH 7.4. The 
associative cortex, the hippocampus, and the striatum were dissected using visual 
landmarks. 
For slice preparation, brain tissues were cut into minces to increase surface area 
for radioactive-tagged neurotransmitter uptake and oxygen/glucose supply. 
Synaptosomal preparation was made as previously described (88). Briefly, brain 
tissues were homogenized at 900 rpm with a motor-driven homogenizer in ice-cold iso-
osmotic solution containing 0.32 M sucrose, 100 uM EDTA, and 5 mM HEPES, pH 7.4. 
Debris and nuclei were pelleted by differential centrifugation at 900 x g at 4°C for 10 min, 
and supernatant containing synaptosomes was pelleted at 11,500 x g at 4°C for 20 min. 
Final pellets were resuspended in ice-cold aerated (95% O2,5% CO2) Krebs-bicarbonate-
HEPES buffer (KBH) composed of the following (in mM): NaCl, 118; KC1, 3.5; CaCl2, 
1.25; MgS04, 1.2; KH2PO4, 1.2;NaC03,25; HEPES-NaOH, 5, (pH 7.4); D-glucose, 11.5, 
and allowed to equilibrate for at least 30 min on ice. For catecholamine release 
measurement, ascorbic acid, 0.6 mM; EDTA (ethylene-diamine-tetra-acetic acid), 0.1 
mM; and pargyline, 0.01 mM was added to KBH buffer to reduce chemical oxidization, 
free radical formation, and monoamine oxidase (MAO) mediated rapid catecholamine 
metabolism. 
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Measurement of Radioactive-tagged Neurotransmitter Release from Slices 
Neurotransmitter release was measured as described previously (88). To label 
endogenous neurotransmitter pool, hippocampal slices were incubated for 30 min with 
173 nM [3H]-norepinephrine (NE) (l-[7, 8-3H] norepinephrine, 35.0 Ci/mmol specific 
activity, Amersham Biosciences). Frontal associative cortex and striatal slices were 
incubated with 110 nM [3H]-dopamine (DA) (3, 4-[ring-2, 5, 6-3H]-
dihydroxyphenylethylamine hydrochloride, 55 Ci/mmol specific activity, PerkinElmer) 
for 30 min at 35°C in freshly bubbled KBH buffer with pargyline addition. Next, slices 
were transferred to a superfusion chamber (0.1 ml chamber volume) containing a glass 
fiber filter (GF/B) and superfused continuously with bubbled KBH (warmed to 35°C, 0.2 
ml/min superfusion rate) for 40 min to remove un-incorporated radioactivity. Three 3-
min fractions of the superfusate were collected to determine basal level of efflux, then, 
evoked release was triggered by rapid switching of superfusion lines from normal KBH 
to a KBH containing 50 mM KC1, for 1.5 min to induce neuronal depolarization. In the 
depolarizing buffer the NaCl concentration was reduced from 118 mM to 72.7 mM in 
order to maintain iso-osmolarity. The total of nine superfusate fractions was collected 
continuously throughout the experiment. 
Measurement of Radioactive-tagged Neurotransmitter Release from Synaptosomes 
To label endogenous neurotransmitter pools, synaptosomes were incubated with 
173 nM [3H]-NE (l-[7, 8-3H] norepinephrine, 35.0 Ci/mmol specific activity, Amersham 
Biosciences) for 5 min at 35°C in freshly bubbled KBH. To simultaneously measure both 
glutamate and GABA release, 115 nM [3H]-glutamate (L-[3, 4-3H]-glutamic acid, 52.0 
Ci/mmol specific activity, PerkinElmer, Boston, MA) and 73 nM [14C]-GABA (4-
35 
aminobutyric acid-earboxy-14C, 8.3 Ci/mmol specific activity, SIGMA) were added to 
synaptosomes for 5 min at 35°C in freshly bubbled KBH. Labeled synaptosomes were 
transferred to a superfusion chamber (0.1 ml chamber volume) containing a glass fiber 
filter (GF/B) covered with 50 ul of 50% Sephadex slurry, and superfused with 
continuously bubbled KBH (warmed to 35°C, 0.8 ml/min superfusion rate) for 12 min to 
remove un-incorporated radioactivity. Three 1-min fractions of the superfusate were 
collected to determine basal neurotransmitter efflux (basal release). Release was induced 
by rapid switching of superfusion lines from normal KBH to a KBH containing 0.5 M 
sucrose for 30 sec to produce a temporary hyperosmotic shock. The total of nine 
superfusate fractions was collected continuously throughout the experiment. 
Determining Radioactivity and Calculating Neurotransmitter Release 
Tritium and/or 14C contents of individual fractions and activity remaining in the 
superfusion chamber was counted at the end of the experiment by liquid scintillation 
spectrometer (LS 3801, Beckman Instruments, Inc., Fullerton, CA), which was calibrated 
and validated in the range of expected radioactivity efflux values. 14C and 3H decay emit 
different energy spectra (18.3 keV, 156 keV, respectively), allowing separate detection. 
Release was expressed as the fractional release rate, calculated as the fraction of 
radioactivity released at any given time divided by the amount remaining in sample 
preparation at that particular time point. Total evoked release was calculated from the 
area under the peak. 
Statistics 
Effects of radiation dose and time course between 3 and 6 month points were 
analyzed by Kruskal-Wallis one-way ANOVA on ranks followed by Dunn's method for 
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pair-wise comparisons (SigmaStat 2.03). Treatment effects in comparison with controls 
were evaluated with Student's i-test or non-parametric Mann-Whitney Rank Sum test 
(SigmaStat 2.03) when normality tests failed. Significance was considered at P < 0.05. 
RESULTS 
Point six Gy of56Fe (1 GeV/n) radiation produced a significant inhibitory effect on [ HJ-
glutamate efflux from the hippocampal synaptosomes 
Iron-56 induced CNS effects have several characteristics in common, e.g. either 
an extremely steep dose-response curve or the lack of a dose-response relationship 
depending on the measured endpoint (61). To evaluate 56Fe radiation dose effect on the 
hippocampal nerve terminal, I have tested three doses; 0.6, 1.4, and 2.0 Gy. 
Dose-response analysis on 0.5 M sucrose-evoked [3H]-glutamate efflux revealed 
that 0.6 Gy of 56Fe radiation (1 GeV/n) produced the most significant inhibitory effect 
(14.9 ± 3.61% of control, P = 0.02, Kruskal-Wallis one-way ANOVA followed by 
Dunn's pairwise comparison) three months after exposure (filled circle) (Fig. 11), while 
1.4 Gy radiation did not significantly alter evoked release (9.6 ± 7.06% of normal). These 
results suggest that the threshold for this biochemical endpoint may be equal or lower 
than 0.6 Gy three months post irradiation. 
Furthermore, six months after exposure (open circle), the inhibitory effect induced 
by 0.6 Gy persisted (25.0 ± 5.23% of normal, P = 0.002, Kruskal-Wallis one-way 
ANOVA followed by Dunn's pairwise comparison), while the effects of > 1.4 Gy of Fe 
radiation were non-significant. Based on these findings, I choose to use a single dose of 
0.6 Gy to further investigate biochemical effects of 56Fe radiation on hippocampal 
neurotransmission. 
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FIG. 11. Dose effects of 56Fe radiation (1 GeV/n) on hyperosmotic sucrose evoked 
[3H]-glutamate efflux from hippocampal synaptosomes at three (filled circle) and six 
(open circle) months post irradiation. * indicates significant differences from controls (P 
< 0.05), analyzed with Kruskal-Wallis one-way ANOVA followed by Dunn's pairwise 
comparison. 
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Figure 12A shows representative experiment on effects of 0.6 Gy of 56Fe radiation 
on [3H]-glutamate release from hippocampal synaptosomes. While basal release, 
observed the first 4 minute time window, was not significantly affected (95.6 ± 2.08% of 
control, Figs. 12B, C), hyperosmotic sucrose evoked [3H]-glutamate efflux from 
hippocampal synaptosomes observed 5 and 6 minute time window was significantly 
reduced (85.2 ± 3.61% of control, P = 0.01, Mann-Whitney Rank Sum Test, Figs. 12B, 
Effects of 0.6 Gy of56Fe radiation (1 GeV/n) were more pronounced on hippocampal 
than associative cortical synaptosomes. 
Glutamate is the principal excitatory neurotransmitter in the brain, and is 
abundant in the hippocampus as well as in the cortex (70, 96). To determine if the same 
dose of 56Fe particles exerts inhibitory effect on glutamatergic nerve terminals of 
different brain regions, I have evaluated [3H]-glutamate release from the associative 
cortex. Associative cortex is functionally distinct cortical area, located in the anterior part 
of the cortex, which includes prefrontal cortex (PFC). The basic function of the brain area 
is to orchestrate goal oriented behavior. Associative cortical glutamatergic system is 
vulnerable to aging, and aging induced reduction of glutamate content in the area was 
documented(64). 
My results showed that 0.6 Gy of 56Fe radiation did not disturb [3H]-glutamate 
release in associative cortical nerve terminals when tested three months after exposure 
(Fig. 13). Normalized basal and 0.5 M sucrose evoked release were 93.8 ± 4.27% and 
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FIG. 12. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on [3H]-glutamate release from 
rat hippocampal synaptosomes three months post irradiation. (A) Representative 
experiment. Glutamate release was evoked from superfused synaptosomes by 30 sec 
pulses of hypertonic sucrose (arrow). (B) Summary graph of experiments indicating the 
fractional release of [3H]-glutamate basal and hypertonic sucrose evoked release 
calculated as the area under the peak. (C) Fractional release values under normal 
conditions were set to 100% and treatment effects were normalized to control. Graphs 
show means ± SEM (n = 8, each). *': P < 0.05. 
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FIG. 13. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on [3H]-glutamate release from 
associative cortical synaptosomes three months post irradiation. (A) Representative 
experiment. Glutamate release was evoked in superfused synaptosomes by 30 sec pulses 
of hypertonic sucrose (arrow). (B) Summary graph of experiments indicating the 
fractional release of [3H]-glutamate basal and hypertonic sucrose evoked release 
calculated as the area under the peak. (C) Fractional release values under normal 
conditions were set to 100% and treatment effects were normalized to control. Graphs 
show means ± SEM (n - 3, each). 
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95.5 ±3.05%, respectively. The results suggest that hippocampal glutamatergic nerve 
terminals are more sensitive to 0.6 Gy of 56Fe particle radiation. 
Point six Gy of56Fe radiation (1 GeV/n) produced a significant inhibitory effect on 
hippocampal GABA release 
My next question was whether the inhibitory effect of 0.6 Gy of 56Fe radiation 
was selective for glutamatergic nerve terminals. To address this question, I labeled 
hippocampal synaptosomes with [14C]-GABA as well as [3H]-glutamate to compare both 
release in the same preparation. [14C]-GABA is incorporated through nerve terminal and 
synaptic vesicle transporters, while [3H]-glutamate is incorporated by a different set of 
nerve terminal transporters (GLT-1 and EAAC1) and synaptic vesicle transporter (VGlut). 
Release was triggered by a pulse of hypertonic sucrose, and 14C and 3H contents were 
simultaneously collected, as described earlier. 
Evoked [14C]-GABA efflux highly correlated with that of [3H]-glutamate (Fig. 14, 
R2 = 0.893). 0.6 Gy of 56Fe radiation reduced evoked [14C]-GABA release significantly 
(82.5 ± 6.06% of control, P < 0.001, Mann-Whitney Rank Sum Test), while basal evoke 
was not altered (97.6 ± 2.62%, n.s., Fig. 15). These data indicate that inhibitory effect of 
0.6 Gy of 56Fe radiation on hippocampal nerve terminals was not selective to the 
glutamatergic system, and that the same cellular defects may underlie the functional 
impairments in both glutamatergic and GABAergic functions. 
Effects of 0.6 Gy of36Fe radiation were not significant on hippocampal noradrenergic 
system 
I have also tested the effects of 0.6 Gy of 56Fe particles on noradrenergic 
terminals in the hippocampus. Although a trend of decrease was observed in the size of 
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FIG. 14. Correlation between evoked [3H]-glutamate release and [14C]-GABA release. 
Hippocampal synaptosomal preparation was double labeled with [3H]-glutamate and 
[14C]-GABA. High correlation (R2= 0.893) indicates effects of 0.6 Gy of 56Fe radiation 
(1 GeV/n) was not selective for neurotransmitter types. 
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56T r 1 4 , FIG. 15. Effects of 0.6 Gy of 30Fe radiation (1 GeV/n) on ['TJ-GABA release from 
rat hippocampal synaptosomes three months post irradiation. (A) Representative 
experiment. GABA release was evoked in supeffused synaptosomes by 30 sec pulses of 
hypertonic sucrose (arrow). (B) Summary graph of experiments indicating the fractional 
release of [14C]-GABA basal and hypertonic sucrose evoked release calculated as the area 
under the peak. (C) Fractional release values under normal conditions were set to 100% 
and treatment effects were normalized to control. Graphs show means ± SEM (n = 8 of 
control, n = 7 of irradiated). *:P<0.05 
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evoked release, it was not statistically significant (91.5 ± 5.20% of control, P = 0.343, Fig. 
16). Basal release was spared (107.7 ± 10.65% of control). 
The inhibitory effects of 0.6 Gy of 56Fe radiation on [ HJ-glutamate and [ CJ-GABA 
release persisted at 6 month post irradiation 
To test the temporal changes in HZE induced neurotransmitter release, I have 
evaluated the effects of 0.6 Gy of 5^Fe radiation six months after irradiation (Fig. 17). The 
results revealed that the effects were persistent on both glutamatergic (evoked release; 
75.2 ± 5.23% of control, P < 0.05) and GABAergic release (75.8 ± 3.65 of control, P < 
0.005) compared to control. There was a statistically significant difference in time course 
effect (glutamatergic, P = 0.002; GABAergic, P < 0.001, Kruskal-Wallis one-way 
ANOVA), indicating a possible progressive effect, although measures taken at 3 months 
and 6 months were not statistically different. Basal levels of both systems were not 
changed: glutamatergic, 103.8 ± 2.33%; GABAergic, 99.6 ± 6.00%. There was no effect 
observed in either basal or evoked release from noradrenergic nerve terminals. 
DISCUSSION 
I found that 0.6 Gy of 56Fe radiation (1 GeV/n) led to significant reduction in 
hypertonic sucrose evoked release, a measure of the readily releasable pool (RRP), of two 
major neurotransmitters, glutamate and GABA, at three months after exposure. Moreover, 
these effects were persistent until six months post radiation. 
While further studies with lower doses need to be carried out, 0.6 Gy may be a 
threshold dose for inducing impairments in hippocampal glutamatergic and GABAergic 
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FIG. 16. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on [3H]-norepinephrine (NE) 
release from rat hippocampal synaptosomes three months post irradiation. (A) 
Representative experiment. NE release was evoked in superfused synaptosomes by 30 sec 
pulses of hypertonic sucrose (arrow). (B) Summary graph of experiments indicating the 
fractional release of [3H]-NE basal and hypertonic sucrose evoked release calculated as 
the area under the peak. (C) Fractional release values under normal conditions were set to 
100% and treatment effects were normalized to control. Graphs show means ± SEM (n = 
8, each). 
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FIG. 17. Three and six months post irradiation effects of 0.6 Gy of 56Fe radiation (1 
GeV/n) on basal (A) and evoked release (B) from hippocampal synaptosomes. Graphs 
show means ± SEM•(*; P < 0.05 compared to control, analyzed by Kruskal-Wallis one-
way ANOVA followed by Dunn's pairwise comparison, n = 5-8). 
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neurotransmission. It is of note that the lowest dose we tested induced the largest deficits 
in hippocampal neurotransmission. This finding is in line with dose response studies for 
the induction of ROS by 56Fe radiation (26). Limoli and co-authors found that in a range 
of low dose (0.25 ~'l Gy) of 56Fe particles, ROS production was linear until a peak was 
reached at 1 Gy. After that point, ROS production started to decline. Rabin and co-
workers also documented that the dose-response curve of 56Fe particle induced changes in 
neurochemical function are extremely steep (61). They observed a significant reduction 
in K+-depolarization evoked striatal DA release by doses 0.1 to 0.5 Gy, but there was no 
effect when dose was increased to 5 Gy. Thus, my results are consistent with the 
characteristics of 56Fe irradiation reported by others. 
In contrast to glutamatergic and GABAergic impairments, release from the 
noradrenergic nerve terminals was not significantly changed by the same regimen of 
irradiation. It is noteworthy that 2.0 Gy of 56Fe particle could induce significant reduction 
in depolarization evoked [3H]-norepinephrine release from slices of rat hippocampus 
(Chapter I, Preliminary Results), suggesting that threshold dose to cause perturbation in 
hippocampal noradrenergic neurotransmission may be higher than 0.6 Gy. Alternatively, 
it is possible that other elements of neurons, not terminals, which are preserved in slices, 
but not in synaptosomes, may be direct targets of radiation. 
Glutamate and GABA are the two major neurotransmitters in the hippocampus 
and are involved in cognitive functions. The hippocampus is vulnerable to aging, and 
numerous studies suggest that disintegrating glutamatergic neurotransmission is a factor 
in aging (64, 97, 98). It is noteworthy that radiation accelerates aging, and the similarity 
of aged rats and 56Fe irradiated rats in measures of nigrostriatal system dependent 
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functions (5) and in hippocampal dependent spatial learning and memory (9) have been 
noted. 
My results also indicate that the effect of 0.6 Gy of 56Fe radiation is region 
specific; glutamatergic chemical transmission was disturbed in nerve terminals of the 
hippocampus, while it was normal in the associative cortex. The nature of this region 
specificity is difficult to discern at the present level of investigation. One possible 
explanation may be regional differences in antioxidative activities. Todorovic et al. found 
that after 2.0 Gy of y-radiation exposure mitochondrial superoxide dismutase (SOD) 
activity was significantly lower in the hippocampus than in the cortex (37). Considering 
that mitochondrial SOD is induced in response to radiation, and that neurons cannot 
tolerate the depletion of mitochondrial SOD, their finding, at least partially, may explain 
the higher radio- vulnerability of the hippocampus. 
Despite significant reduction in evoked release in glutamatergic and GABAergic 
nerve terminals, basal release remained unchanged in both nerve terminals. Basal release 
reflects spontaneous release, which is independent of action potential depolarization. 
Studies have shown that spontaneous release may originate from a different vesicle pool 
from the RRP with different states of releasability (92). The exact nature of the molecular 
diversity between these two vesicle pools remains to be identified, although it has been 
suggested that isoforms of SNARE proteins involved in basal release are different from 
those participated in evoked (92, 93). My findings of unaltered basal release and 
significantly altered evoked release, thus, suggest that radiation effects may have spared 
proteins underlining spontaneous release, and also the basic release machinery. 
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The question still remains, however, as to the locus of the radiation-induced 
deficit(s) in perturbation of glutamatergic and GABAergic release. The extent of 
hypertonic sucrose evoked release probes the size of the RRP, which reflects the rate of 
recycling of synaptic vesicles during extended stimulation (99). Upon depletion of 
vesicles in RRP, vesicles are replenished from a reserve pool. Reduction in release might 
reflect radiation induced change in size of the reserve pool, or total size of the recycling 
pool, which combines both RRP and the reserve pool. To test this, I have investigated 
effects of 56Fe radiation on the abundance of synaptic vesicles by quantitative analysis of 
synaptic vesicle marker proteins (Chapter III). 
Moreover, significant influence on the size of release originates Ca dynamics, 
which depends on: 1) numbers and types of voltage-gated Ca2+channels.; 2) Ca + 
buffering and transient local Ca2+ concentration; and 3) Ca2+-binding property of Ca2+ 
sensor (86, 99). These factors will influence the size of hyperosmotic sucrose evoked 
release, even though the stimulus itself does not require influx of Ca2+. Thus, any change 
that alters composition and tension of the participating membranes of the active zone 
influences neurotransmitter release, even by simply stretching the membrane (100). 
Considering oxidative effects induced by radiation and increased levels of lipid 
peroxidation previously documented (27, 36), there may be possible alterations in 
membrane structure and fluidity after 0.6 Gy 56Fe irradiation. Consequence of lipid 
peroxidation is unregulated membrane potential (101), which may imbalance cytoplasmic 
Ca2+ concentration and ultimately affects Ca2+ dependent steps of the synaptic vesicle 
cycle. I have tested the level of lipid peroxidation in the hippocampus, and obtained 
supportive results (Chapter IV). 
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CHAPTER III 
EFFECTS OF HZE RADIATION ON 
SELECTED SYNAPTIC PROTEIN LEVELS 
BACKGROUND 
In the previous chapter I reported significant reduction of hypertonic sucrose 
evoked release from glutamatergic and GABAergic nerve terminals in the hippocampus, 
three and six months after exposure to 0.6 Gy of 56Fe radiation. The reduction could be a 
reflection of radiation induced depletion of synaptic vesicle pools. To address this, I 
assayed synaptic vesicle marker protein levels in hippocampal synaptosomes after 56Fe 
irradiation. Synaptophysin was used as a general marker of all synaptic vesicle types and 
VGlutl (vesicular glutamatergic transporter 1) was used as a marker of glutamatergic 
synaptic vesicles. 
Neurotransmitter receptor levels are differentially regulated during development 
(102), and in synaptic plasticity processes (103). Membrane structure and fluidity (62) 
and radiation (25) also affect neurotransmitter receptor levels. Because of the importance 
of those proteins in glutamatergic, GABAergic and noradrenergic transmission, I 
determined levels of glutamatergic AMP A (a-amino-3-hydroxy-5 -methyl -4-isoxazole-
propionic acid) and NMDA (N-methyl D-aspartate) receptors (NR1, NR2A and NR2B), 
GABAergic (y-amino butyric acid) GABAA and G A B A B receptors, and noradrenergic al , 
a2 and pi adrenergic receptors after 0.6 Gy of 56Fe radiation exposure. 
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PSD-95 (postsynaptic density 95 kDa), a scaffold protein which anchors 
glutamatergic receptors, was also tested to evaluate whether number or size of excitatory 
postsynaptic contacts were affected. 
To probe a possible neuronal regeneration as compensatory response after 
irradiation, I also have analyzed the level of MAP2 (microtubule associated protein 2), 
which is involved in the stabilization and extension of dendrites (104). 
Each protein is discussed in the following sections. 
Synaptophysin 
Synaptophysin is a synaptic vesicle associated protein that constitutes about 7% 
of the total vesicle proteins (105). Due to its ubiquity at all types of synaptic vesicles, it 
has been widely used as a general marker for nerve terminals (106, 107). Synaptophysin 
interacts with an essential SNARE protein (soluble N-ethylmaleimide-sensitive factor 
attachment protein receptor), synaptobrevin (also referred to as VAMP, vesicle associated 
membrane protein). Exact function of the synaptophysin-synaptobrevin complex is 
largely unknown, however it is speculated that synaptophysin may temporally restrict 
availability of synaptobrevin by binding to it (106). 
Since synaptophysin levels positively correlate with the number of synaptic 
vesicles (68), I have used this protein as a general marker of total synaptic vesicle pool in 
nerve terminals. 
VGlutl 
VGlutl is a transporter of glutamate into synaptic vesicles. VGlutl is driven by an 
ATP dependent electrochemical proton gradient. Since VGlut is exclusive to vesicles 
containing glutamate, and undetectable in other neuron types or neuronal components 
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(77), it has been used as a marker for glutamatergic synaptic vesicles and nerve terminals. 
Two isoforms, VGlutl and VGlut2, are identified in glutamatergic synapses. Both mRNA 
(75) and protein (108) levels of VGlutl are predominant in hippocampus, thus, VGlutl is 
more extensively used for hippocampal studies (108). 
A recent study showed diminished VGlutl expression in the hippocampus and 
prefrontal cortex of schizophrenic patients, suggesting usefulness of this marker in 
pathological studies (75). Glutamate is a ubiquitous amino acid in neural tissue and 
participates in a variety of intermediary metabolisms. For example, glutamate functions 
in the detoxification of ammonia, is a building block in the synthesis of proteins and 
peptides including glutathione, and is a precursor in GABA synthesis. Only 20 to 30% of 
neural glutamate content functions as an excitatory neurotransmitter. 
To evaluate 56Fe radiation effects on glutamate as a neurotransmitter, I assayed 
VGlutl levels, as a measure of total glutamatergic synaptic vesicle pool. 
Glutamatergic receptors 
A recent study showed that rats subjected to a clinically relevant regimen of 
radiation induced significant reduction in performance of hippocampus dependent 
learning tasks, and also that the same regimen altered NMD A receptor levels in the 
hippocampus, indicating a role of NMDA receptors in radiation induced cognitive 
impairments (25). The importance of glutamatergic NMDA receptors in LTP (40) and 
LTD (73) has been well documented, providing a strong link between the glutamatergic 
systems and the mechanisms of learning and memory (40, 74). These results prompted us 
to evaluate NMDA receptor levels after 56Fe irradiation. 
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The NMDA receptor functions as a glutamate gated ion channels that is highly 
permeable to Na+ and Ca2+. Mg2+ blocks this NMDA channels in a voltage-dependent 
manner, thus, rendering NMDA receptors voltage sensitive. NMDA receptors are 
heterometric complexes consisting of obligatory NR1 and various NR2 subunits. The 
NR1 subunit serves as a key subunit essential for ion selectivity of the NMDA channels, 
whereas the NR2 subunit mainly participates in channel gating by voltage and Mg . Liu 
and co-authors reported that distinct NMDA subunits were critical factors to determine 
the direction of synaptic plasticity (73). They found that the activation of NR2A-
containing NMDA receptors led to LTP formation, while the activation of NR2B-
containing NMDA receptor produced LTD (73). Although this is still under debate, e.g. 
other group demonstrated NR2B's involvement in LTP (109), general consensus is that 
the combinations of NR1 with different NR2 subunits give rise to functional diversity. 
To probe the effects of HZE radiation on these functionally different subunits, I 
have used antibodies against NR1, NR2A and NR2B subunits. 
In addition, I have extended our investigationto AMP A receptors, another type of 
glutamatergic ionotropic receptors, which possess mostly Naf-permeable channels. 
Excessive release of glutamate may cause overload of cellular Na+ and Ca2+ through 
these glutamatergic ionotropic receptors, leading to excitotoxic cell death. Such scenario 
may play a role in cerebral ischemia and traumatic brain injury, and also, in chronic 
neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS) (110), 
Parkinson's disease (111) and Alzheimer's disease (112). 
AMPA receptors respond faster to glutamate than NMDA receptors and mediate 
the bulk of rapid excitatory synaptic current induced by glutamate (113). Previous results 
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showed that LTP requires insertion of new AMP A receptors to the synapse by a 
mechanism that involves the association between GluRl AMPA subunit and a PDZ 
domain protein, such as PSD-95 (discussed below) {114). 
To probe the effects of HZE radiation on levels of AMPA receptors, I have used 
antibody against GluRl subunit. 
GABAergic receptors 
GAB A is the major inhibitory neurotransmitter in the adult hippocampus and 
can hyperpolarize postsynaptic membrane by influx of CI" through GABAA receptors. 
Metabotropic GABAB receptors are coupled to cAMP, K+ channel or Ca2+ channel 
regulation. Behavioral studies have suggested that GABAB receptor blockade can 
improve cognition (41). 
To probe the effects of HZE radiation on levels of GAB A receptors, I have used 
antibody against GABAA and GABAB subunits. 
Noradrenergic receptors 
NE is a neuromodulator and plays a prominent role in learning tasks (44). It 
transmits the effects through three subtypes of receptors; i.e. Gq-coupled al-, Gi-coupled 
a2-, and Gs-coupled pi-adrenergic receptors. NE activates cAMP-dependent PKA and 
calmodulin-dependent protein kinase (CaMKII) via (31 adrenergic receptors, and 
stimulation of pi adrenergic receptors leads to profound effects on the induction of LTP 
in multiple hippocampal pathways (42, 43, 115). NE also modulates LTP through al 
adrenergic receptors (43, 81, 82), and reduces LTP through Gi-coupled <x2 adrenergic 
receptors (116). Since NE is released during emotional arousal, its involvement in 
emotional influence on learning and memory has been suggested. Supporting this notion, 
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recent study showed that NE-driven phosphrylation of GluRl subunit of-AMPA receptors 
facilitates synaptic delivery of AMP A receptors in LTP expression (117). 
To test for possible radiation effects on noradrenergic signal transmission, I have 
used antibodies against al-, a2- and (31-adrenergic receptors in this study. 
PSD-95 
The postsynaptic compartment of excitatory synapses is characterized by an 
electron-dense region, referred to as the postsynaptic density (PSD) (indicated by small 
arrows in Figure 9) that consists of adhesion molecules, neurotransmitter receptors, and 
high density of scaffolding proteins. PSD-95 (PSD-95 kDa) is a major scaffold protein 
enriched at glutamatergic postsynaptic membranes. By homomultimerizing through N-
terminus, PSD-95 molecules form a scaffold. PSD-95 contains three PDZ domains (a 
domain commonly discovered in PSD-95/Dlg/ZOl proteins), which anchor various 
proteins such as adhesion molecules, e.g. neuroligin-1, glutamatergic NMDA receptors, 
and through an adapter protein, stagazin, glutamatergic AMP A receptors. PSD-95 
controls subcellular localization of glutamatergic receptors by facilitating alignment of 
postsynaptic receptors with the presynaptic active zone. 
The reduced glutamatergic release we observed (Chapter II) may produce a 
coordinated reduction in the levels of PSD-95. To test this possibility, I have determined 
PSD-95 levels by immunoblotting. 
MAP2 
Microtubules are major structural components of the neuronal cytoskeleton in 
axons and dendrites. MAPs (microtubule-associated protein) are a family of proteins 
involved in neuromorphogenesis, among which MAP2 is the best characterized. In 
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mature neurons MAP2 is compartmentalized within dendrites of neurons {118) and 
largely excluded from axons (119). It forms microtubule bundles with straight and rigid 
appearance (120). MAP2 also plays an important role in the extension of the dendritic 
cytoskeleton and in dendritic stability by forming cross-bridge between microtubules and 
other cytoskeletal elements (104). Multiple lines of evidence also indicate that MAP2 
levels correlate with neuronal response to oxidative stress (121, 122). Treatments with 
H2O2 led to a remarkable reduction in MAP2 levels, while antioxidant treatments up-
regulated MAP2 levels. 
The MAP2 family consists of three isoforms, MAP2a, 2b and 2c. Each has 3 to 4 
microtubule-binding repeats near the C-terminus (123) and an N-terminal projection 
domain of varying size, which has a net negative charge and exerts a long-range repulsive 
force (124) that regulates microtubule spacing (118). MAP2a and 2b are large proteins 
with longer projection domains (Mw 280 kDa), while MAP2c, which is often highly 
expressed during early development, is smaller (Mw 70 kDa). Different MAP2 isoforms 
may have distinct capacities in stabilizing the cytoskeleton. And MAP2c may have the 
highest capacity to interact with both microtubules and F-actin (125). It induces neurite 
initiation by reorganizing a primary actin-rich structure into a secondary microtubule-rich 
structure (122). 
MAP2c may have at least two phosphorylated sites, and is a substrate for a 
number of protein kinases (126). It has been suggested that MAP2 phosphorylation state 
may modify microtubule stability, and thus, regulate neuronal development (126, 127). 
Previous studies found that highly phosphorylated MAP2c showed a lower affinity for 
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microtubule, resulting in decreases in microtubule bundling (126), although precise 
functions of individual phosphorylation sites are not known. 
I measured MAP2c levels as an index of dendritic neuronal response to radiation 
induced oxidative stress. 
MATERIALS AND METHODS 
Sample Preparation for Western Blotting 
Samples were prepared from hippocampal tissues as described earlier (Chapter II, 
Materials and Methods, Sample Preparation). After thawing frozen samples on ice, 
tissues from 4 to 6 animals were pooled. This was necessary for obtaining reliable signals 
in the dynamic range of detection from low density synaptic proteins. Pooled tissues were 
homogenized in isotonic sucrose containing 0.32 M sucrose, 100 uM EDTA, and 5 mM 
HEPES, pH 7.4, and synaptosomes were prepared. Total protein concentration in SI 
fractions was determined using the Coomassie Plus better Bradford assay kit (Pierce) 
according to manufacturer's instructions. 
Simultaneous Detection of Two Proteins on Western Blots using Two Near-Infrared (IR) 
Fluorophores 
Synaptosomes were suspended in SDS-PAGE sample buffer with 8 M urea and 
2% mercaptoethanol, and incubated at 60°C for 20 min to accelerate protein denaturing. 
Proteins were separated on 3% polyacrylamide stacking and 7.5% running gels for 20 
min at 80 V followed by 40 min at 150 V, then transfer to nitrocellulose membrane 
(Whatman, Dassel, Germany) for 1 h at 1.5 A in a high intensity field kept at room 
temperature by a cooling coil (Bio-Rad, Hercules, CA). Membranes were blocked in 
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buffer containing 5% nonfat milk and 5% porcine serum in TBST (Tris-buffered saline 
Tween-20) containing Tris 20 mM, NaCl 134 mM, pH 7.6 with 0.1% v/v Tween-20 for 
30 min at room temperature, and then incubated with primary antibodies overnight at 4°C. 
I utilized Odyssey (Li-Cor) Multiplexed Detection which uses two IR 
fluorescence channels for simultaneous analysis of two targets. Two primary antibodies 
from different host species were incubated together to probe a blot; rabbit antibody 
against a protein of interest, and mouse antibody against loading controls, actin or vasolin 
containing protein (VCP). After washing with PBS (phosphate buffered saline) 
containing 0.01 M phosphate buffer, 2.7 mM KC1, and 137 mM NaCl, pH 7.4 with 1% 
Tween-20, incubation with two IR-conjugated secondary antibodies was carried out for 1 
hour at room temperature. Five washes were carried out to remove nonspecific antibody 
binding in PBS with 1% Tween-20, or plain PBS. 
Visualization of the Western blot signals from two IR fluorophores was done 
using the Odyssey IR Imaging System (LICOR, Lincoln, NE) in 700 and 800 nm 
channels in a single scan at 42 urn high resolution. Quantification was performed with 
Odyssey Application Software version 2.1 (LICOR, Lincoln, NE). 
Integrated intensity signal was normalized for loading controls to gain a measure 
independent of sample loading errors. For each specific protein, I optimized general 
immunoblotting parameters (Table 2) and determined the linear range of IR fluorescence 
signal, by loading different protein amounts of the sample. 
In some cases where the two primary antibodies were raised in the same species, 
diluent dilutions factor of secondary antibody were determined to obtain conditions with 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































were assayed in duplicates for each experiment, and each experiment was repeated at 
least three times. 
Antibodies 
The rabbit polyclonal antibodies against; NR2A, TSTR1 and GluRl were purchased 
from Millipore (Temecula, CA), NR2B, al,and pi were from Abeam (Cambridge, MA), 
GABAA was from BD Biosciences (San Jose, CA), a2 was from Neuromics (Edina, MN), 
and VGlutl and MAP2 were from Synaptic Systems (Goettingen, Germany), The mouse 
monoclonal antibodies against synaptophysin, actin, PSD-95, GABAB and VCP were 
purchased from BD Biosciences (San Jose, CA). Goat anti-rabbit or goat anti-mouse 
antibodies conjugated to IR dyes (IRDye 800CW, IRDye 680, respectively, were 
purchased from LI-COR, Lincoln, NE). 
Statistics 
The results were analyzed by Student's Mest to evaluate treatment effects in 
comparison with sham-control. Time course effects were evaluated by Kruskal-Wallis 
one-way ANOVA followed by Dunn's pairwise comparison to assess three and six 
months post radiation effects. Differences between means were considered significant at 
P<0.05. 
RESULTS 
Reduction of [ HJ-glutamate release was not due to decrease in nerve terminal number 
or in glutamatergic synaptic vesicle number. 
My findings on 0.6 Gy of 56Fe radiation induced reduction in RRP (Chapter II 
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Background in detail) raised the possibility of nerve terminal loss or reduced 
glutamatergic synaptic vesicle numbers. I have assessed the levels of VGlutl and 
synaptophysin in hippocampal synaptosomes obtained from rats subjected to Fe 
irradiation to investigate synaptic vesicle densities on nerve terminal, 
VGlutl antibody detected a single band at approximately 70 kDa (Fig. 18B). The 
synaptophysin antibody also detected a single band migrating at approximately 40 kDa 
(Fig. 18B). These immunoreactive bands corresponds to the previously published 
molecular weights of VGlutl (70-80 kDa) and synaptophysin (38 kDa) (106, 108). 
Normalized levels of integrated intensity showed that 56Fe radiation did not have a 
significant effect on VGlutl or synaptophysin immunoreactivity (Fig 18A, Table 3) three 
and six months post irradiation. These results suggest that radiation did not cause global 
changes in glutamatergic nerve terminal population, or in glutamatergic synaptic vesicle 
numbers. 
0.6 Gy of56Fe radiation significantly reduced levels ofNMDA, but not AMP A receptors . 
3 months post irradiation 
It was previously reported that ionizing radiation affected glutamatergic NMDA 
receptor levels (25). I assessed NMDA and AMPA receptor abundance in hippocampal 
synaptosomes obtained from rats subjected to 0.6 Gy of 56Fe irradiation. The NR1 
antibody detected a strong band at 120 kDa, and the NR2A antibody detected a strong 
band at 170 kDa (Fig. 19B). The NR2B antibody detected two bands at approximately 
180 kDa and 150 kDa. The lower band was probably a product of proteolytic degradation 
(128). Our results showed that degradation rate calculated as intensities of 150 kDa over 
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FIG. 18. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on VGIutl and synaptophysin 
levels. Protein levels were analyzed by quantitative western blotting, using VGIutl and 
synaptophysin antibodies. Data were normalized to sham irradiated values, which was set 
to 1. Data shown are means ± SEMs. (A) Summary graph of VGIutl and synaptophysin 
(Syn) levels in hippocampal synaptosomes three and six months post irradiation. (B) 
Representative immunoblots of VGIutl and synaptophysin (Syn) with loading controls, 
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FIG. 19. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on selected glutamatergic 
receptor levels. Protein levels were analyzed by quantitative western blotting. Data were 
normalized to sham irradiated values, which was set to 1. Data shown are means ± SEMs. 
(A) Summary graph of NMDA NR1, 2A, 2B and AMPA GluRl levels in hippocampal 
synaptosomes three and six months post irradiation. (B) Representative immunoblots. *: 
P < 0.05 analyzed by Student's Mest compared to control. 
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The 150 kDa unit is a constituent of the NMD A receptor complex. It is stable and 
maintains basic properties, suggesting functionality (128). Thus, I added up intensities 
from both bands to quantify NR2B levels. A representative band at 180 kDa is shown in 
Figure 19B. The AMPA antibody detected a strong band at 100 kDa. 
For all three NMD A receptor subunits, normalized integrated intensity was 
significantly reduced three months post irradiation, while AMPA receptor 
immunoreactivity was spared (Fig 19A, Table 3). The effects were statistically significant, 
and were more pronounced on NR2 subunits. Both NR2A and NR2B isoform levels were 
reduced by « 20% (NR2A: 0.79 ±0.02 of control: NR2B, 0.78 ± 0.07 of control). 
Six months post irradiation, however, the levels returned to normal. The levels of 
NR2 subunits were comparable to controls, whereas NR1 levels were up-regulated by 
28%. Statistical analysis revealed a significant time course effect on NR1 receptors 
between three and six months (Kruskal-Wallis one-way ANOVA on ranks followed by 
Dunn's pairwise comparison, P = 0.004). AMPA levels were unaltered six months post 
irradiation. 
Radiation exposure did not change PSD-95 levels 
Either directly or indirectly, reduction in glutamatergic release and level of 
NMD A receptors might produce a coordinated change in a major glutamatergic receptor 
scaffolding protein, PSD-95. The PSD-95 antibody I used detected a single band at 
approximately 95 kDa, as expected (Fig. 20B). Three months after exposure the level of 
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FIG. 20. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on PSD-95 levels. Protein 
levels were analyzed by quantitative western blotting, using PSD-95 antibodies. Data 
were normalized to sham irradiated values, which was set to 1. Data shown are means ± 
SEMs. (A) Summary graph of PSD-95 levels in hippocampal synaptosomes three and six 
months post irradiation. (B) Representative imniunoblots. 
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significant (Fig. 20A, Table 3). The level was unchanged when tested six months after 
irradiation (0.91 ±0.14 of controls). 
pi adrenergic receptor displayed significant radio-sensitivity 3 months post irradiation, 
whereas GABA and a-adrenergic receptors did not. 
In addition to glutamatergic receptors, I have evaluated levels of GABAergic and 
noradrenergic receptors. I found both GABAA and GABAB receptors were relatively 
resistant to 0.6 Gy of 56Fe irradiation. The levels of these receptors did not show any 
significant changes in comparison with control at either 3 or 6 month time point (Table 3). 
Among three noradrenergic receptors tested, only the level of pi adrenergic receptor was 
significantly reduced three months after irradiation (Fig. 21, Table 3), while a subunits of 
adrenergic receptors were not altered (Table 3). p receptor levels returned to normal six 
months post irradiation (Table 3). 
Radiation induced a reduction in MAP2c levels 3 months post irradiation that recovered 
6 months post irradiation 
To assess the possibility of neurite degeneration/regeneration, I tested MAP2 
levels in hippocampal synaptosomes. The MAP2 antibody detected two strong bands for 
MAP2 isoforms at approximately 280 kDa (MAP2a and 2b), and 70 kDa (MAP2c), as 
previously documented {129). Thirty percent of total signal came from MAP2c alone 
(30.9 ± 3.92% in sham-control). The results verified that MAP2c, which is highly 
expressed during early neuronal development (118), was still detectable in the 4 - 7 
months old test subjects. Although MAP2a/2b levels did not significantly change, 
MAP2c levels showed significant changes both at three and six months post irradiation. 
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FIG. 21. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on |31 adrenergic receptor 
levels. Protein levels were analyzed by quantitative western blotting. Data were 
normalized to sham irradiated values, which was set to 1. Data shown are means ± SEMs. 
(A) Summary graph of J31 adrenergic receptor levels in hippocampal synaptosomes three 
and six months post irradiation. (B) Representative immunoblots. *: P < 0.05 analyzed by 
Student's Mest compared to control. 
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electrophoretic mobility, which may be due to different phosphorylation states (126) (Fig. 
22B). The highest electrophoretic mobility MAP2c species (band 1), which showed the 
strongest immunoreactivity, is likely to be in de-phosphorylated state. Levels of band 1 
showed 14% reduction three months after exposure (Fig 22A, P = 0.02, Student's /-test). 
More interestingly, at six months post-irradiation, intensity of this MAP2c species were 
up-regulated by 24% in comparison with sham-control (Fig 22A, P = 0.01). The 
difference in the mean values between these two time points was statistically significant 
(one-way ANOVA;P< 0.001). 
As thephosphorylated states of MAP2c species, i.e. band 2 /band 1 and band 3 / 
band 1 ratios, were unaltered at three months post irradiation, no radiation effects on 
phosphorylation were suggested. However, at six months post irradiation, band 3 / band 1 
ratio was significantly reduced compared to control by 20%, indicating reduced 
phosphorylation state of MAP2c. Since MAP2c species in de-phosphorylated state are 
more likely to regulate microtubule growth and stability (126), the band 1 level results, 
i.e. reduction at 3 months and up-regulation at 6 months post irradiation, suggest 
dendritic degeneration and dendritic growth, respectively, which may correspond with 
our findings on NMDA and pi receptor levels. 
DISCUSSION 
The most significant finding in this study was the inhibitory effects of 0.6 Gy of 
56Fe radiation on the levels of glutamatergic NMDA receptors and pi adrenergic 
receptors. For all three NMDA receptor subunits tested, namely NR1, NR2A and NR2B, 
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FIG. 22. Effects of 0.6 Gy of 56Fe radiation (1 GeV/n) on MAP2c levels. Protein 
levels were analyzed by quantitative western blotting. Data were normalized to sham 
irradiated values, which was set to 1. Data shown are means ± SEMs. (A) Summary 
graph of MAP2c (Band 1) levels in hippocampal synaptosomes three and six months post 
irradiation. (B) Representative immunoblots. *: P < 0.05 analyzed by Student's Mest 
compared to control. 
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NMD A receptor levels in the hippocampus are considerably associated with impairments 
in learning and memory. Specifically, L-AP5, a NMD A receptor antagonist, blocks the 
induction of LTP in the hippocampus and decreases spatial memory performance (130). 
Also, knockout mice lacking the obligatory NR1 subunit exhibit impaired LTP and 
spatial memory performance (131). Moreover, preferential inhibition of NR2A subunits 
prevented the induction of LTP, and selective blocking of NR2B subunit abolished the 
induction of LTD (73). Furthermore, we have detected severe reduction of the level of pi 
adrenergic receptors, which also play a critical role in LTP induction (82). Thus, my 
finding on HZE radiation induced reduction of these receptor levels provides a potential 
link between HZE radiation and radiation-induced cognitive dysfunction. 
In contrast, glutamatergic AMPA receptor levels were unchanged. This result is 
consistent with a previous radiation research. Shi and co-workers found that 45 Gy of 
Cs radiation, a dose for the treatment of brain tumors, induced significant alternation in 
NMDA receptor, but not in AMPA receptors. The nature of this specificity is difficult to 
discern from the present experiments, however, it is reported that NMDA possesses a 
unique reduction-oxidation site and ROS oxidizes the sulfhydryl residues associated with 
this site (132), which facilitates vulnerability of NMDA receptors to oxidative stress (64, 
132). Twenty to fifty percent decreases in the density of NMDA receptors during aging 
have been reported, probably due to age related oxidative stress (64). In accordance with 
these reports, pi adrenergic receptor is also susceptible to oxidative stress (133), and the 
level declines by pretreatment with H2O2 (134) and also with age (135). Consequently, 
we presume the specificity of effects of HZE radiation on levels of neurotransmitter 
receptors may associate with susceptibility of each receptor to oxidative stress. 
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Levels of a scaffold protein, PSD-95, was not significantly altered after radiation 
exposure. Thus, we speculate that the observed reduction in NMDA receptors did not 
influence number or size of downstream postsynaptic contacts. The result is in line with 
previous studies, which suggested relatively less functional association of PSD-95 with 
NMDA receptors. Mice lacking PSD-95 show normal NMDA receptor clustering and 
function, but reduced AMP A receptor function (136). In addition, over-expression of 
PSD-95 did not influence NMDA receptor clustering, but enhanced AMPA receptor 
recruitment in developing hippocampal neurons (137). It is likely that a predominant role 
of PSD-95 may be to regulate AMPA receptor insertion and retention at the synapse, 
therefore, that PSD-95 has the closer association with AMPA receptors. My finding of 
unaltered levels of AMPA is consistent with this notion. 
Questions still remain about the unaltered receptor levels 6 months post 
irradiation. I speculate that a possible "repair mechanism" may take place after radiation 
damage. Recovery of HZE radiation induced damage on dendritic spine was previously 
reported, e.g. decrease in dendritic spine length of CA1 hippocampal neurons was less 
severe after one year (65). My finding in MAP2c levels also supports the possible 
recovery. Pronounced reduction in MAP2c level was found at 3 months post irradiation, 
whereas the level was up-regulated 6 months post irradiation. MAP2 provides scaffolds 
in dendrites and facilitates the localization of signal transduction apparatus there, 
particularly near dendritic spines (127). The correlation with levels of NMDA NR1 
subunit and MAP2c suggest some degree of dendritic spine recovery at 6 months. This 
cellular process likely affected NMDA receptor sub-synaptic domains more specifically, 
since levels of AMPA receptors, which are also localized to dendritic spines but within 
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the distinct domains (138), were unaltered in our experiments. 
My study on two synaptic vesicle markers assure that 0.6 Gy of 56Fe irradiation 
did not affect synaptic vesicle stores in the hippocampus, thus, depletion of glutamate 
stores or apoptotic damage of nerve terminals are unlikely to be a cause of reduction in 
glutamatergic release observed in our experiments (Chapter II). In line with my results, a 
previous study using a higher dose (2.0 Gy) of 56Fe radiation also reported unaltered 
levels of synaptophysin in hippocampus (139), supporting the notion that 
neurotransmitter stores are not the direct locus of radiation-induced deficits. 
Overall, my findings on reduced levels of glutamatergic NMD A and pi 
adrenergic receptors, both of which are critical in synaptic plasticity and in learning and 
memory, provide mechanistic evidence underlying HZE radiation induced cognitive 
dysfunction. 
Although there were overall changes in neurotransmitter release (Chapter II) and 
neurotransmitter receptor levels by HZE irradiation, there were a number of differences. 
Regarding the time course of the HZE effects, I observed persisting suppression of 
evoked glutamate and GAB A release, but a recovery in NMD A and pi adrenergic 
receptor levels. Also, while both glutamate and GABA release were suppressed, only the 
NMDA type glutamate receptors changes, leaving GABA receptors unchanged. 
Moreover, while NE release was not affected, pi adrenergic receptor levels were reduced 
at 3 months post irradiation. These findings suggest that the effects of HZE radiation in 
neurotransmitter release and neurotransmitter receptor levels are either completely 
independent or subjected to complex interactions that may involve homeostatic regulation. 
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CHAPTERVI 
HZE RADIATION INDUCED LIPID PEROXIDATION 
BACKGROUND 
As we documented in Chapter II, 56Fe radiation (0.6 Gy, 1 GeV/n)) induces 
significant reduction in hippocampal neurotransmitter release. The results raised a 
question on the integrity of cell membrane in the hippocampus after radiation exposure. 
One important factor that affects the membrane integrity is lipid peroxidation, a 
consequence of oxidative stress. Lipid peroxidation leads to disturbance of Ca 
homeostasis that may affect functions of release machinery (discussed in Chapter II). To 
test this possibility, I have measured levels of lipid peroxidation in the hippocampus three 
and six months post irradiation. 
Oxidative stress can be perceived as an imbalance of cellular pro-oxidant and 
anti-oxidant processes, resulting in the generation of ROS. The brain by nature provides 
favorable environments for generation of ROS (47). It consumes 20% of the oxygen 
utilized by the body, although the brain itself comprises only 2% of the body weight. 
Despite the high ratio of aerobic glycolysis, neurons contain relatively lower levels of 
antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase 
compared with other organs in the body (140). Moreover, the brain is exceptionally 
vulnerable to lipid peroxidation, for neurons contain high levels of peroxidizable fatty 
acids (141). 
Ionizing radiation is capable of producing a variety of ROS (26, 27, 30). HZE 
radiation is a type of high LET (linear energy transfer) radiation, and predominant effects 
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involve direct ionization. Peroxide (H2O2) pretreatment have been used extensively to 
study free radical chemistry of HZE radiation (28, 29, 142), whereas water radiolysis, in 
which indirect effect of ionizing radiation leads to the formation of hydroxyl radicals 
("OH), has been used to model low-LET type radiation such as X-rays (101). 
H2O2 is a ROS, but it is a non-radical and is relatively unreactive. It is converted 
to highly reactive 'OH in the presence of decompartmentalized Fe ions: 
Fe2+ 
i 
H202 + e- -» OH- + "OH 
Because "OH is high reactive, its diffusion radius is only 0.3 nm (141). Diffusible H2O2 
penetrates cell membranes, whose thickness is between 6 ran to 10 ran, and contributes to 
a short-lived 'OH to be distributed both intra- and extracellularly. Thus, "OH is able to 
contact oxidative targets of hydrophobic lipid tails in the cell membrane and becomes a 
major source of lipid peroxidation products. 
Treatment of a hippocampal slice with H2O2 altered electrophysiological 
properties including decreased ability to generate action potentials (29). The treatment 
also increased lipid peroxidation, raising the possibility that the electrophysiological 
effects were mediated by a lipid peroxidation mechanism (30). In line with the finding, 
H2O2 suppressed K+-stimulated [3H]-glutamate release by 20% using cortical 
synaptosomal preparation (31). Pretreatment with antioxidants including iron chelator 
revealed that "OH, but not H2O2, was responsible for the observed effects (30). These 
results suggested that impairments in hippocampal neurotransmission after HZE 
irradiation may be mediated by lipid peroxidation. 
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Previous studies using dichlorofluorescein (DCFH) assay showed that 1.5 Gy of 
Fe radiation led to increased ROS production in the frontal cortex of rats one month 
after exposure (139). Limoli and co-authors also demonstrated that a lower dose of 56Fe 
radiation (< 1.0 Gy) could elicit significant increase in ROS production in hippocampal 
precursor cells one month post irradiation (26). Another line of evidence showed that 
whole body irradiation with 1.5 Gy of 56Fe particles substantially augmented lipid 
peroxidation in mice cerebellum one months post irradiation, and exposure also impaired 
the reference memory (27). Although the above studies support a role for ROS 
production and lipid peroxidation in HZE radiation induced brain damage, there are no 
reports that directly correspond to our experimental conditions. Therefore, we have 
estimated the levels of lipid peroxidation in the hippocampus three and six months post 
0.6 Gy of 56Fe irradiation. 
Lipid peroxidation is oxidative degradation of lipids (LH) by ROS (X"), such as 
OH". Most often affected is the methylene group (-CH2-) in polyunsaturated fatty acids, 
which possess reactive hydrogen to produce unstable lipid radical (L-); 
1) LH + X' -> L' + XH (Initiation) 
Lipid radical readily reacts with O2 to produce lipid peroxyl radical (LOO"); 
2) L' + 0 2 -» • LOO" 
Reaction can propagate, and eventually changes the membrane structure; 
3) LOO" + LH -» LOOH + L" (Propagation) 
Hydroperoxides (LOOH) result in production of a series of new reactive species, e.g. 4-
hydroxyalkenals (HAE) and malondialdehyde (MDA); 
4) LOOH -> short chain radicals, reactive aldehydes 
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The radical chain continues to proceed, until it is terminated; 
5) LOO' + LOO' -> non-radical product (Termination) 
As this bimolecular scheme illustrates, LOO' possesses paradoxical abilities to serve in 
both propagation and termination, which explains the inverse dose-response effect at 
radiation induced lipid peroxidation {101, 143). The inverse dose-response means that 
high production rates of free radiais, which initiate lipid peroxidation, yield a smaller 
amount of reactive end products than low production rates. This is distinct from the dose-
response of radiation effects, where high dose is more effective than low dose. It is 
noteworthy that these secondary reactive species such as L", LOO', as well as 
degradation products of LOOH, are also capable to interact with lipids and membrane 
proteins. 
The alteration of membrane structures leads to increased membrane permeability. 
Inactivation of ion channels and increase of unspecific membrane leak was found after 
oxidative insult (101). These allow membrane depolarization (144) and non-specific Ca + 
influx (145). An important pathophysiological consequence is disruption of Ca 
homeostasis and alteration of neural transmission. 
I assayed levels of MDA and HAE, end products of LOOH (Eq. 4). 
Measurements of them have been used as an indicator of lipid peroxidation. As a result, I 
have found that 0.6 Gy of 56Fe radiation (1 GeV/n) induced high levels of lipid 
peroxidation in the hippocampus three months post irradiation. The high levels persisted 
six months post irradiation. 
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MATERIALS AND METHODS 
Sample Preparation 
Hippocampus was dissected and stored at -80°C to prevent loss of MDA and HAE, 
and to prevent further oxidation. Frozen samples were thawed on ice. Tissues from 4 
animals were pooled, and then homogenized in ice-cold PBS containing 5 mM butylated 
hydroxytoluene (BHT), an antioxidant, to prevent new lipid peroxidation during 
homogenization. Homogenates were centrifuged at 3000 x g at 4°C for 10 min to pellet 
cell debris. Aliquots of supernatant were taken to determine protein concentration using 
the Coomassie Plus better Bradford assay kit (Pierce) according to manufacturer's 
instructions. Protein concentration of samples was adjusted to 15 - 60 mg/ml. Samples 
were kept on ice until use. 
Lipid Peroxidation Assay 
Measurement of MDA in combination with HAE was performed using a micro-
plate assay kit (Oxford Biomedical Research, Oxford, MI) according to the 
manufacturer's directions. The assay is based on a color reaction of a chromogenic 
reagent, N-methyl-2-phenylindole, with MDA and HAE. One molecule of either MDA or 
HAE reacts with 2-molecules of the reagent to yield a stable chromophore with 
absorbance at 570 nm. Samples were added to the reagent, and incubated at 45°C for 60 
min, followed by centrifugation at 15,000 x g for 10 min to obtain a supernatant clear 
from precipitates. Values were expressed as MDA + HAE nmol/mg protein. Samples 




The results were analyzed by Student's /-test. Differences between means were 
considered significant at P < 0.05. 
RESULTS 
Point six Gy of 56Fe radiation (1 GeV/rt) leads to a significant increase in lipid 
peroxidation in the hippocampus three and six months post irradiation 
My results showed that the level of MDA + HAE was about two times higher in 
0.6 Gy irradiated samples than in the sham control animals (control: 1.8 ± 0.30 nmol/mg 
protein; irradiated: 3.8 ± 0.82 nmol/mg protein, P < 0.05, Student's t-test,n = 4, Fig. 23.) 
The effects persisted six months post irradiation (irradiated: 4.0 ± 0.48 nmol/mg protein, 
P < 0.05, Student's /-test, n = 4, Fig. 23.) 
The temporal correlation between lipid peroxidation and reduction in 
hippocampal glutamate and GAB A transmitter release caused by 0.6 Gy of 56Fe radiation 
raises the possibility of a causal relationship. 
DISCUSSION 
My results demonstrate an inverse relationship between hippocampal 
neurotransmitter release and level of lipid peroxidation in the hippocampus of animals 
exposed to 0.6 Gy of 56Fe radiation. These two phenomena correlated well and the 
inverse relationship persisted even through 6 months. This delayed effect of oxidative 
insults on membrane might be a contributing factor to the observed reduction of 
hippocampal neurotransmission. 
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FIG. 23. Point six Gy of 56Fe radiation (1 GeV/n) induced changes in products of lipid 
peroxidation in the hippocampus. Levels of lipid peroxidation were evaluated as 
described in the Materials and Methods. Briefly, hippocampal homogenate was loaded 
with a chromogenic reagent, iV-methyl-2-phenylindole at 45°C for 60 min, and lipid 
peroxidation was assessed by measuring the levels of MDA (malondialdehyde) in 
combination with a derivative, HAE (4-hydroxyalkenals) at three months and six months 
post irradiation. Values are expressed as means of MDA + HAE (nmol/mg protein) ± 
SEM. Asterisks indicate statistical significance analyzed by two- tail Student's Mest. (n 
= A). 
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Radiation induced lipid peroxidation is a non-enzymatic random reaction (146), 
but extremely common phenomena in the brain. It is noteworthy that this radiation 
induced insult was one of a few uniform responses among irradiated subjects, based on a 
long-term investigations after the Chernobyl nuclear accident (45). Generally, radiation 
effects display high variability among subjects due to different radio-sensitivity of each 
individual. 
While previous studies focused on the early delayed effects of HZE radiation on 
ROS production (147) and lipid peroxidation (27) detected one month post irradiation, 
my results indicate that the effects can persist well beyond one month, for as long as 6 
months, suggesting that production of ROS can be continuous and may play a critical role 
in late delayed effects of HZE radiation on neurotransmission. Mechanistic explanation 
of this prolonged membrane oxidization is beyond the scope of this study, however, it has 
been suggested that paradoxical ability of reactive species, which both initiate and 
terminate chain reaction that results in lipid peroxidation, might be relevant to prolonged 
production (143). In order to terminate the chain of events, it is necessary to reduce lipid 
hydroperoxides as well as to decompose concomitant formation of LOO". Consequently, 
the role of endogenous antioxidants has received extensive attention. It is likely that an 
optimal concentration of antioxidants may exist that will restore the free radical level to 
yield the best combination of inhibition and termination to minimize net lipid 
peroxidation, and any concentration other than this optimal leads to increased, thus, 




The main findings of the present study were: 1) 0.6 Gy of 56Fe radiation (1 
GeV/n) significantly perturbed chemical neurotransmission of rat hippocampal nerve 
terminals, resulting in a persisted reduction of hypertonic sucrose evoked [3H]-glutamate 
and [14C]-GABA release; 2) exposure to 0.6 Gy of 56Fe radiation also significantly 
reduced levels of glutamatergic NMDA receptors as well as pi adrenergic receptors three 
months post irradiation, however, partial repair may take place by six months post 
irradiation; 3) the same radiation regimen significantly enhanced oxidative stress as 
indicated by increased levels of lipid peroxidation products in the hippocampus both 
three and six months post irradiation, suggesting that increased levels of lipid 
peroxidation played an important role in reduction of neurotransmitter release. 
Although it is presently untested whether these alterations within the 
hippocampus directly contribute to aspects of radiation induced cognitive impairments, 
our findings demonstrate that, after a single dose of 56Fe radiation as low as 0.6 Gy, the 
neurochemical environment in the hippocampus becomes significantly altered, which 
may underlie impairments in cognitive functions. It is of importance that synaptic 
plasticity may be significantly altered via reduction of NMDA and pi adrenergic receptor 
levels in the hippocampus. 
Although precise mechanisms are still under debate, a generally accepted model 
of radiation-induced cognitive dysfunction is depicted in Figure 24. In this classic 
paradigm, neuronal cell death due to radiation induced generation of ROS leads to cell 
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FIG. 24. Classic paradigm of radiation-induced cognitive dysfunction. The solid 
arrows indicate the generally accepted sequence of events from the absorption of 
radiation to the expression of the various forms of biological damage, which 
consequently leads to cognitive dysfunction. Dotted line indicates postulated 
neurogenesis hypothesis (19, 36). Dashed line indicates a pathway proposed by the 
present work. 
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loss and/or tissue damage, which can deteriorate functions of the CNS (46). With high 
dose radiation exposure, white matter necrosis is the dominant histopathological 
presentation and consistently associated with demyelination (47). Demyelination impairs 
the conduction of action potentials, and consequently impairs cognitive performance. 
Whereas high doses of radiation produce overt histopathological changes, lower dose 
exposures produce cognitive dysfunction without inducing obvious morphological 
changes. Recently it was reported that radiation impaired neurogenesis via 
neuroinflammatory process. Two Gy of 56Fe radiation reduced the rate of proliferation 
among neuronal progenitors within the dentate gyrus, and also impaired hippocampus 
dependent performance (19, 36). My findings with 0.6 Gy, which is regarded sub-
threshold for impairing neurogenesis, raise the possibility that HZE radiation could cause 
functional deficits in cognitive behavior without involving neurogenesis or 
histopathological changes as previously proposed (dashed line in Fig. 24). 
Overall, this work contributes to Phase 1 of NASA Strategic Program Plan by 1) 
uncovering a risk to the integrity of hippocampal chemical neurotransmission in the CNS, 
and 2) collecting specific evidence for radiation induced alterations in synaptic functions 
/ elements that are critical for normal cognitive functions. 
In future studies, I would like to further extend my investigation to 1) validate 
permissible exposure limits using a series of our assays. Also, assuming that lipid 
peroxidation may at least partially underlie the observed reduction in neurotransmitter 
release, optimized concentration of cellular antioxidants may rescue the radiation induced 
deficits. Thus, the current assays would facilitate to: 4) develop effective mitigation 
strategies. Pretreatment with RGS scavengers, such as polyethylene glycol-conjugated 
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catalase (PEG-CAT), a cell permeable H2O2 scavenging enzyme, may reduce radiation-
induced deficiencies. Also, diet antioxidants, such as vitamin E, are known to inhibit lipid 
peroxidation and might ameliorate HZE radiation effects on neurotransmission. 
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